Motif ID: Sp1
Z-value: 1.820
Transcription factors associated with Sp1:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Sp1 | ENSMUSG00000001280.6 | Sp1 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Sp1 | mm10_v2_chr15_+_102406143_102406380 | -0.28 | 1.5e-02 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 7.5 | 52.8 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 6.2 | 18.5 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
| 5.6 | 22.4 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 5.1 | 15.4 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) |
| 5.0 | 15.1 | GO:0099548 | trans-synaptic signaling by nitric oxide(GO:0099548) |
| 5.0 | 15.0 | GO:0021837 | motogenic signaling involved in postnatal olfactory bulb interneuron migration(GO:0021837) positive regulation of mitotic cell cycle DNA replication(GO:1903465) |
| 5.0 | 24.8 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
| 4.7 | 14.2 | GO:0032765 | positive regulation of mast cell cytokine production(GO:0032765) |
| 4.6 | 18.5 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 4.6 | 13.7 | GO:0030827 | negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 4.1 | 16.3 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 4.0 | 16.2 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
| 4.0 | 12.1 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 4.0 | 12.1 | GO:1903002 | regulation of lipid transport across blood brain barrier(GO:1903000) positive regulation of lipid transport across blood brain barrier(GO:1903002) |
| 3.7 | 14.8 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
| 3.7 | 3.7 | GO:0010544 | negative regulation of platelet activation(GO:0010544) |
| 3.6 | 18.1 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 3.6 | 18.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 3.6 | 17.8 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 3.5 | 10.6 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 3.5 | 17.6 | GO:0070384 | Harderian gland development(GO:0070384) |
| 3.5 | 13.9 | GO:0072069 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 3.4 | 10.3 | GO:0017055 | negative regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0017055) |
| 3.4 | 3.4 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
| 3.4 | 10.1 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
| 3.3 | 16.7 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
| 3.3 | 26.5 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 3.3 | 26.4 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
| 3.3 | 9.8 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
| 3.2 | 12.8 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
| 3.2 | 32.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 3.1 | 12.5 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
| 3.1 | 9.4 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 3.1 | 21.7 | GO:0003096 | renal sodium ion transport(GO:0003096) |
| 3.1 | 9.2 | GO:0071317 | cellular response to isoquinoline alkaloid(GO:0071317) |
| 3.1 | 12.2 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
| 3.0 | 15.2 | GO:0015871 | choline transport(GO:0015871) |
| 3.0 | 3.0 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
| 3.0 | 3.0 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
| 3.0 | 14.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 2.9 | 17.6 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 2.9 | 17.2 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
| 2.9 | 20.1 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 2.8 | 8.5 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
| 2.8 | 11.2 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 2.8 | 8.4 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 2.8 | 44.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 2.8 | 19.3 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 2.7 | 2.7 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 2.7 | 13.5 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 2.7 | 2.7 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 2.7 | 8.1 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 2.7 | 8.0 | GO:0002447 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 2.7 | 21.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 2.6 | 7.9 | GO:0042323 | negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 2.6 | 23.4 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 2.6 | 10.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 2.6 | 18.0 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 2.5 | 2.5 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 2.4 | 4.9 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 2.4 | 9.8 | GO:0021564 | glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 2.4 | 12.2 | GO:0090005 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 2.4 | 2.4 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 2.4 | 17.0 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
| 2.4 | 2.4 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
| 2.4 | 9.6 | GO:0097298 | regulation of nucleus size(GO:0097298) |
| 2.4 | 12.0 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
| 2.4 | 14.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 2.4 | 14.2 | GO:0042756 | drinking behavior(GO:0042756) |
| 2.3 | 4.6 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
| 2.3 | 9.2 | GO:1903288 | positive regulation of potassium ion import(GO:1903288) |
| 2.3 | 2.3 | GO:0007521 | muscle cell fate determination(GO:0007521) |
| 2.2 | 15.7 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
| 2.2 | 2.2 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 2.2 | 2.2 | GO:1900673 | olefin metabolic process(GO:1900673) |
| 2.2 | 8.9 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 2.2 | 6.6 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
| 2.2 | 6.6 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 2.2 | 6.6 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 2.1 | 2.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 2.1 | 17.1 | GO:0048625 | myoblast fate commitment(GO:0048625) |
| 2.1 | 8.5 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 2.1 | 6.3 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 2.1 | 14.8 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
| 2.1 | 6.3 | GO:0061075 | cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 2.1 | 6.3 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
| 2.1 | 8.4 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
| 2.1 | 8.3 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
| 2.0 | 8.2 | GO:0090472 | dibasic protein processing(GO:0090472) |
| 2.0 | 6.1 | GO:1902022 | L-lysine transport(GO:1902022) |
| 2.0 | 2.0 | GO:0014889 | muscle atrophy(GO:0014889) |
| 2.0 | 14.1 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
| 2.0 | 12.0 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 2.0 | 15.9 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
| 2.0 | 5.9 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 2.0 | 5.9 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 1.9 | 9.7 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
| 1.9 | 13.5 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
| 1.9 | 1.9 | GO:0044805 | late nucleophagy(GO:0044805) |
| 1.9 | 3.8 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
| 1.9 | 3.8 | GO:1901629 | regulation of presynaptic membrane organization(GO:1901629) |
| 1.9 | 11.4 | GO:0097473 | cellular response to light intensity(GO:0071484) cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
| 1.9 | 20.9 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 1.9 | 1.9 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 1.9 | 22.7 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
| 1.9 | 9.4 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
| 1.9 | 5.6 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 1.8 | 3.7 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 1.8 | 5.5 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
| 1.8 | 9.1 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
| 1.8 | 9.0 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
| 1.8 | 5.4 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 1.8 | 5.4 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 1.8 | 7.2 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 1.8 | 5.4 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
| 1.8 | 8.9 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 1.8 | 3.5 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 1.8 | 5.3 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 1.8 | 5.3 | GO:0019043 | establishment of viral latency(GO:0019043) |
| 1.8 | 7.0 | GO:0031348 | negative regulation of defense response(GO:0031348) |
| 1.8 | 8.8 | GO:0002317 | plasma cell differentiation(GO:0002317) |
| 1.8 | 10.5 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 1.8 | 1.8 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 1.7 | 1.7 | GO:1905072 | cardiac jelly development(GO:1905072) |
| 1.7 | 7.0 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 1.7 | 5.1 | GO:0001193 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 1.7 | 5.1 | GO:0051542 | elastin biosynthetic process(GO:0051542) |
| 1.7 | 25.3 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 1.7 | 1.7 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 1.7 | 5.0 | GO:0006507 | GPI anchor release(GO:0006507) |
| 1.7 | 11.6 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 1.7 | 5.0 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 1.7 | 5.0 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
| 1.6 | 1.6 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
| 1.6 | 1.6 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 1.6 | 4.9 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 1.6 | 8.2 | GO:0070417 | cellular response to cold(GO:0070417) |
| 1.6 | 13.1 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
| 1.6 | 4.9 | GO:0015866 | ADP transport(GO:0015866) |
| 1.6 | 4.9 | GO:2000564 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
| 1.6 | 8.2 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 1.6 | 8.1 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 1.6 | 6.5 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 1.6 | 9.6 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 1.6 | 4.8 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
| 1.6 | 4.8 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
| 1.6 | 6.4 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 1.6 | 4.8 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 1.6 | 3.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 1.6 | 7.9 | GO:0008355 | olfactory learning(GO:0008355) |
| 1.6 | 6.3 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 1.6 | 6.3 | GO:0010046 | response to mycotoxin(GO:0010046) |
| 1.6 | 1.6 | GO:0090427 | activation of meiosis(GO:0090427) |
| 1.6 | 11.0 | GO:0015862 | uridine transport(GO:0015862) |
| 1.6 | 6.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 1.6 | 12.5 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 1.6 | 4.7 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 1.6 | 14.1 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 1.6 | 6.2 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
| 1.5 | 6.2 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
| 1.5 | 4.6 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 1.5 | 6.1 | GO:0009405 | pathogenesis(GO:0009405) |
| 1.5 | 9.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
| 1.5 | 16.8 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
| 1.5 | 3.1 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
| 1.5 | 4.6 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 1.5 | 6.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 1.5 | 6.0 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
| 1.5 | 3.0 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
| 1.5 | 4.5 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 1.5 | 4.5 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 1.5 | 4.5 | GO:0030421 | defecation(GO:0030421) |
| 1.5 | 4.5 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) follicle-stimulating hormone secretion(GO:0046884) |
| 1.5 | 4.5 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
| 1.5 | 5.9 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 1.5 | 8.9 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 1.5 | 4.4 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 1.5 | 4.4 | GO:0030974 | thiamine pyrophosphate transport(GO:0030974) |
| 1.5 | 5.8 | GO:1900150 | regulation of defense response to fungus(GO:1900150) |
| 1.5 | 5.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 1.5 | 1.5 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 1.5 | 4.4 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 1.5 | 7.3 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 1.4 | 2.9 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
| 1.4 | 8.7 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
| 1.4 | 14.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 1.4 | 7.2 | GO:0042160 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 1.4 | 11.4 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
| 1.4 | 7.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 1.4 | 4.3 | GO:0048289 | isotype switching to IgE isotypes(GO:0048289) regulation of isotype switching to IgE isotypes(GO:0048293) |
| 1.4 | 5.7 | GO:0048597 | post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 1.4 | 4.2 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 1.4 | 2.8 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
| 1.4 | 4.2 | GO:0015886 | heme transport(GO:0015886) |
| 1.4 | 4.2 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
| 1.4 | 1.4 | GO:1901678 | iron coordination entity transport(GO:1901678) |
| 1.4 | 1.4 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 1.4 | 5.6 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
| 1.4 | 4.2 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 1.4 | 6.9 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 1.4 | 1.4 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 1.4 | 4.1 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 1.4 | 2.7 | GO:0061743 | motor learning(GO:0061743) |
| 1.4 | 1.4 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 1.4 | 2.7 | GO:0042448 | progesterone metabolic process(GO:0042448) |
| 1.3 | 6.7 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 1.3 | 4.0 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 1.3 | 20.0 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
| 1.3 | 2.7 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
| 1.3 | 1.3 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 1.3 | 5.3 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 1.3 | 4.0 | GO:0071929 | alpha-tubulin acetylation(GO:0071929) |
| 1.3 | 6.6 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 1.3 | 5.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 1.3 | 28.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 1.3 | 1.3 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) |
| 1.3 | 10.4 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 1.3 | 3.9 | GO:0051004 | regulation of lipoprotein lipase activity(GO:0051004) |
| 1.3 | 3.9 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 1.3 | 2.6 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 1.3 | 2.6 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) |
| 1.3 | 11.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 1.3 | 1.3 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
| 1.3 | 5.1 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 1.3 | 11.4 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 1.3 | 3.8 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
| 1.3 | 6.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
| 1.3 | 12.6 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
| 1.3 | 3.8 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
| 1.3 | 2.5 | GO:0021586 | pons maturation(GO:0021586) |
| 1.2 | 7.5 | GO:0051958 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 1.2 | 1.2 | GO:0035509 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
| 1.2 | 1.2 | GO:0090003 | regulation of Golgi to plasma membrane protein transport(GO:0042996) regulation of establishment of protein localization to plasma membrane(GO:0090003) |
| 1.2 | 3.7 | GO:0061744 | motor behavior(GO:0061744) |
| 1.2 | 13.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 1.2 | 20.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 1.2 | 3.7 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 1.2 | 4.9 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 1.2 | 1.2 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 1.2 | 8.5 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 1.2 | 2.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
| 1.2 | 6.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
| 1.2 | 2.4 | GO:0097494 | regulation of vesicle size(GO:0097494) |
| 1.2 | 2.4 | GO:0070375 | ERK5 cascade(GO:0070375) |
| 1.2 | 1.2 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 1.2 | 7.2 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
| 1.2 | 3.6 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 1.2 | 2.4 | GO:0035905 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 1.2 | 4.7 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 1.2 | 9.5 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 1.2 | 1.2 | GO:0048865 | stem cell fate commitment(GO:0048865) stem cell fate specification(GO:0048866) |
| 1.2 | 4.7 | GO:0006710 | androgen catabolic process(GO:0006710) |
| 1.2 | 4.7 | GO:1904451 | regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 1.2 | 1.2 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
| 1.2 | 3.5 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 1.2 | 8.2 | GO:0015879 | carnitine transport(GO:0015879) |
| 1.2 | 5.8 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 1.2 | 7.0 | GO:1903056 | positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 1.2 | 18.5 | GO:0046033 | AMP metabolic process(GO:0046033) |
| 1.2 | 8.1 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 1.2 | 3.5 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 1.2 | 11.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
| 1.2 | 5.8 | GO:0021592 | fourth ventricle development(GO:0021592) |
| 1.2 | 11.5 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
| 1.1 | 3.4 | GO:0010896 | regulation of triglyceride catabolic process(GO:0010896) positive regulation of triglyceride catabolic process(GO:0010898) |
| 1.1 | 4.6 | GO:0030202 | heparin metabolic process(GO:0030202) |
| 1.1 | 6.8 | GO:0003383 | apical constriction(GO:0003383) |
| 1.1 | 3.4 | GO:0071873 | response to norepinephrine(GO:0071873) |
| 1.1 | 5.7 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 1.1 | 9.1 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
| 1.1 | 4.5 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
| 1.1 | 12.5 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 1.1 | 3.4 | GO:1902220 | positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902220) |
| 1.1 | 2.3 | GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
| 1.1 | 1.1 | GO:0061056 | sclerotome development(GO:0061056) |
| 1.1 | 1.1 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
| 1.1 | 11.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
| 1.1 | 1.1 | GO:0036482 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
| 1.1 | 4.5 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 1.1 | 6.7 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
| 1.1 | 5.5 | GO:0071376 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 1.1 | 4.4 | GO:1903294 | regulation of glutamate secretion, neurotransmission(GO:1903294) positive regulation of glutamate secretion, neurotransmission(GO:1903296) |
| 1.1 | 2.2 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 1.1 | 6.6 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 1.1 | 8.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 1.1 | 3.3 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 1.1 | 18.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 1.1 | 4.3 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
| 1.1 | 8.7 | GO:0030578 | PML body organization(GO:0030578) |
| 1.1 | 14.1 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 1.1 | 5.4 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
| 1.1 | 13.0 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
| 1.1 | 3.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 1.1 | 5.4 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 1.1 | 1.1 | GO:2000830 | vacuolar phosphate transport(GO:0007037) vitamin D3 metabolic process(GO:0070640) positive regulation of parathyroid hormone secretion(GO:2000830) |
| 1.1 | 2.1 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
| 1.1 | 9.6 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
| 1.1 | 6.4 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 1.1 | 5.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 1.1 | 9.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 1.1 | 3.2 | GO:1903859 | regulation of dendrite extension(GO:1903859) |
| 1.1 | 10.6 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 1.1 | 3.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 1.1 | 7.4 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 1.1 | 3.2 | GO:0090327 | negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 1.0 | 2.1 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 1.0 | 4.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 1.0 | 4.1 | GO:0009597 | detection of virus(GO:0009597) |
| 1.0 | 1.0 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
| 1.0 | 7.3 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 1.0 | 3.1 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 1.0 | 3.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 1.0 | 5.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 1.0 | 2.0 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
| 1.0 | 8.1 | GO:0051580 | regulation of neurotransmitter uptake(GO:0051580) |
| 1.0 | 8.1 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 1.0 | 6.1 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 1.0 | 2.0 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
| 1.0 | 6.1 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 1.0 | 7.1 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
| 1.0 | 1.0 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) |
| 1.0 | 2.0 | GO:2000282 | regulation of cellular amino acid biosynthetic process(GO:2000282) |
| 1.0 | 2.0 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
| 1.0 | 3.0 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 1.0 | 3.0 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
| 1.0 | 2.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 1.0 | 2.0 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 1.0 | 9.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
| 1.0 | 3.0 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 1.0 | 5.0 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 1.0 | 2.0 | GO:0043379 | memory T cell differentiation(GO:0043379) |
| 1.0 | 3.0 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 1.0 | 3.0 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
| 1.0 | 7.9 | GO:0009181 | purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 1.0 | 3.9 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 1.0 | 45.2 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 1.0 | 4.9 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 1.0 | 5.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 1.0 | 6.9 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 1.0 | 2.0 | GO:0035989 | tendon development(GO:0035989) |
| 1.0 | 1.0 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 1.0 | 8.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 1.0 | 3.9 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 1.0 | 2.9 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 1.0 | 2.9 | GO:1902218 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) |
| 1.0 | 2.9 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 1.0 | 2.9 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 1.0 | 2.9 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 1.0 | 8.6 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 0.9 | 1.9 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.9 | 3.8 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
| 0.9 | 4.7 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.9 | 1.9 | GO:0010507 | negative regulation of autophagy(GO:0010507) |
| 0.9 | 14.0 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.9 | 0.9 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.9 | 2.8 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.9 | 1.9 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.9 | 0.9 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
| 0.9 | 1.8 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.9 | 1.8 | GO:0010273 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.9 | 4.6 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.9 | 3.7 | GO:0015844 | monoamine transport(GO:0015844) |
| 0.9 | 3.6 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
| 0.9 | 5.4 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.9 | 2.7 | GO:0021546 | rhombomere development(GO:0021546) |
| 0.9 | 1.8 | GO:0070305 | response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.9 | 4.5 | GO:0072338 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
| 0.9 | 4.5 | GO:1905169 | protein localization to phagocytic vesicle(GO:1905161) regulation of protein localization to phagocytic vesicle(GO:1905169) positive regulation of protein localization to phagocytic vesicle(GO:1905171) |
| 0.9 | 4.4 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.9 | 8.9 | GO:0032098 | regulation of appetite(GO:0032098) |
| 0.9 | 15.9 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.9 | 3.5 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 0.9 | 1.8 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
| 0.9 | 14.0 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.9 | 2.6 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
| 0.9 | 1.7 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.9 | 3.5 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite regulation of transcription(GO:0045990) |
| 0.9 | 3.5 | GO:0060346 | bone trabecula formation(GO:0060346) |
| 0.9 | 4.3 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
| 0.9 | 7.8 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.9 | 2.6 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
| 0.9 | 4.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.9 | 2.6 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.9 | 2.6 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070424) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070432) |
| 0.8 | 0.8 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.8 | 1.7 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.8 | 13.6 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.8 | 10.2 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.8 | 5.9 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
| 0.8 | 10.1 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
| 0.8 | 7.5 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.8 | 5.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.8 | 5.0 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
| 0.8 | 2.5 | GO:0071313 | cellular response to caffeine(GO:0071313) |
| 0.8 | 5.0 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 0.8 | 2.5 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.8 | 1.7 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
| 0.8 | 4.9 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.8 | 1.6 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
| 0.8 | 4.1 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.8 | 1.6 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) |
| 0.8 | 2.5 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
| 0.8 | 7.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.8 | 2.5 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.8 | 5.7 | GO:0061718 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
| 0.8 | 7.3 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.8 | 3.3 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
| 0.8 | 6.5 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.8 | 1.6 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.8 | 2.4 | GO:0042196 | dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.8 | 7.3 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.8 | 0.8 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
| 0.8 | 2.4 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.8 | 0.8 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.8 | 1.6 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
| 0.8 | 2.4 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.8 | 13.4 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 0.8 | 14.1 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
| 0.8 | 2.4 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
| 0.8 | 3.9 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
| 0.8 | 1.6 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.8 | 1.6 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.8 | 1.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 0.8 | 5.5 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.8 | 1.6 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
| 0.8 | 16.2 | GO:0032933 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.8 | 2.3 | GO:1990743 | protein sialylation(GO:1990743) |
| 0.8 | 1.5 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.8 | 18.4 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.8 | 1.5 | GO:0071672 | negative regulation of smooth muscle cell chemotaxis(GO:0071672) |
| 0.8 | 0.8 | GO:0072010 | renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.8 | 5.3 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.8 | 2.3 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.8 | 3.0 | GO:0002931 | response to ischemia(GO:0002931) |
| 0.8 | 3.8 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.8 | 6.8 | GO:2000489 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) |
| 0.8 | 2.3 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 0.7 | 3.7 | GO:0006007 | glucose catabolic process(GO:0006007) |
| 0.7 | 5.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.7 | 6.0 | GO:0021815 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
| 0.7 | 9.7 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.7 | 8.1 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.7 | 11.6 | GO:0045026 | plasma membrane fusion(GO:0045026) |
| 0.7 | 3.6 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
| 0.7 | 2.2 | GO:0034035 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.7 | 2.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
| 0.7 | 0.7 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.7 | 2.9 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
| 0.7 | 1.4 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
| 0.7 | 2.1 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
| 0.7 | 0.7 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
| 0.7 | 2.8 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
| 0.7 | 4.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.7 | 2.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.7 | 2.1 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.7 | 2.8 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.7 | 1.4 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.7 | 2.8 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.7 | 4.9 | GO:0006561 | proline biosynthetic process(GO:0006561) |
| 0.7 | 0.7 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.7 | 1.4 | GO:0035812 | renal sodium excretion(GO:0035812) |
| 0.7 | 0.7 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.7 | 1.4 | GO:0042940 | D-amino acid transport(GO:0042940) |
| 0.7 | 2.8 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.7 | 1.4 | GO:0035305 | negative regulation of dephosphorylation(GO:0035305) |
| 0.7 | 2.1 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.7 | 2.1 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
| 0.7 | 1.4 | GO:1903626 | positive regulation of DNA catabolic process(GO:1903626) |
| 0.7 | 5.5 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.7 | 2.0 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
| 0.7 | 2.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 0.7 | 3.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.7 | 4.7 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.7 | 2.7 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.7 | 0.7 | GO:0010040 | response to iron(II) ion(GO:0010040) |
| 0.7 | 3.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.7 | 1.3 | GO:0036166 | phenotypic switching(GO:0036166) |
| 0.7 | 1.3 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.7 | 1.3 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
| 0.7 | 10.6 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.7 | 0.7 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
| 0.7 | 6.6 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
| 0.7 | 3.3 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
| 0.7 | 0.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.7 | 3.9 | GO:1903147 | negative regulation of mitophagy(GO:1903147) |
| 0.7 | 9.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.7 | 2.6 | GO:2000671 | regulation of motor neuron apoptotic process(GO:2000671) |
| 0.6 | 2.6 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.6 | 0.6 | GO:0019732 | antifungal humoral response(GO:0019732) antifungal innate immune response(GO:0061760) |
| 0.6 | 1.9 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.6 | 1.9 | GO:0032510 | endosome transport via multivesicular body sorting pathway(GO:0032509) endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.6 | 5.7 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
| 0.6 | 5.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
| 0.6 | 1.9 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.6 | 3.8 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
| 0.6 | 1.9 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
| 0.6 | 1.9 | GO:2000319 | negative regulation of T-helper 17 type immune response(GO:2000317) regulation of T-helper 17 cell differentiation(GO:2000319) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.6 | 1.9 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 0.6 | 1.9 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.6 | 0.6 | GO:0009826 | unidimensional cell growth(GO:0009826) |
| 0.6 | 0.6 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) |
| 0.6 | 7.0 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.6 | 2.5 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.6 | 3.8 | GO:0007032 | endosome organization(GO:0007032) |
| 0.6 | 0.6 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.6 | 0.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 0.6 | 3.1 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.6 | 3.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.6 | 1.3 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.6 | 7.5 | GO:0015816 | glycine transport(GO:0015816) |
| 0.6 | 2.5 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 0.6 | 0.6 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.6 | 0.6 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 0.6 | 7.4 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
| 0.6 | 1.2 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.6 | 1.8 | GO:0009153 | purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.6 | 1.8 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.6 | 1.8 | GO:0046851 | negative regulation of bone remodeling(GO:0046851) |
| 0.6 | 1.8 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.6 | 1.8 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.6 | 6.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.6 | 4.8 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.6 | 1.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
| 0.6 | 6.0 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.6 | 1.2 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.6 | 6.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.6 | 2.4 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.6 | 1.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
| 0.6 | 3.0 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
| 0.6 | 4.7 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.6 | 6.5 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.6 | 1.2 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
| 0.6 | 1.2 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
| 0.6 | 7.1 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.6 | 3.5 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 0.6 | 2.3 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.6 | 3.5 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.6 | 1.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.6 | 3.5 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.6 | 1.2 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.6 | 8.1 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.6 | 9.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
| 0.6 | 2.9 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
| 0.6 | 2.3 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.6 | 0.6 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
| 0.6 | 2.3 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.6 | 0.6 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
| 0.6 | 2.8 | GO:0046686 | response to cadmium ion(GO:0046686) |
| 0.6 | 1.1 | GO:0002484 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.6 | 0.6 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) synaptic vesicle budding(GO:0070142) |
| 0.6 | 1.1 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.6 | 29.9 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
| 0.6 | 0.6 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.6 | 2.8 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.6 | 1.1 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 0.6 | 0.6 | GO:0048369 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
| 0.6 | 0.6 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.6 | 14.6 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
| 0.6 | 3.9 | GO:0032094 | response to food(GO:0032094) |
| 0.6 | 2.8 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
| 0.6 | 3.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.6 | 3.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
| 0.6 | 2.8 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.6 | 6.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.5 | 11.0 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.5 | 1.1 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.5 | 0.5 | GO:1903305 | regulation of regulated secretory pathway(GO:1903305) |
| 0.5 | 2.7 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
| 0.5 | 3.3 | GO:0097421 | liver regeneration(GO:0097421) |
| 0.5 | 1.6 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
| 0.5 | 2.2 | GO:0002347 | response to tumor cell(GO:0002347) |
| 0.5 | 3.2 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.5 | 3.8 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.5 | 4.3 | GO:0019243 | methylglyoxal metabolic process(GO:0009438) methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.5 | 1.1 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
| 0.5 | 2.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
| 0.5 | 2.1 | GO:0061614 | pri-miRNA transcription from RNA polymerase II promoter(GO:0061614) |
| 0.5 | 1.1 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.5 | 0.5 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
| 0.5 | 1.6 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.5 | 0.5 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 0.5 | 4.7 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.5 | 8.9 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.5 | 2.1 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
| 0.5 | 0.5 | GO:1902525 | regulation of protein monoubiquitination(GO:1902525) |
| 0.5 | 0.5 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.5 | 1.0 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.5 | 4.7 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.5 | 1.6 | GO:0032380 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.5 | 1.0 | GO:0003094 | glomerular filtration(GO:0003094) |
| 0.5 | 1.5 | GO:0001941 | postsynaptic membrane organization(GO:0001941) |
| 0.5 | 1.5 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.5 | 3.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
| 0.5 | 0.5 | GO:0033198 | response to ATP(GO:0033198) |
| 0.5 | 3.1 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.5 | 3.5 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.5 | 13.6 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.5 | 0.5 | GO:0060596 | mammary placode formation(GO:0060596) |
| 0.5 | 3.0 | GO:1902065 | response to L-glutamate(GO:1902065) |
| 0.5 | 2.5 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.5 | 4.0 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.5 | 0.5 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.5 | 4.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.5 | 3.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.5 | 1.0 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.5 | 7.4 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 0.5 | 2.0 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.5 | 1.5 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.5 | 4.9 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.5 | 0.5 | GO:1903527 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
| 0.5 | 4.9 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 0.5 | 2.0 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.5 | 2.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.5 | 1.0 | GO:1901798 | positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.5 | 2.9 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
| 0.5 | 4.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.5 | 1.5 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.5 | 2.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.5 | 1.9 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.5 | 1.0 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.5 | 2.9 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
| 0.5 | 7.7 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) negative regulation of response to extracellular stimulus(GO:0032105) negative regulation of response to nutrient levels(GO:0032108) |
| 0.5 | 3.8 | GO:2000378 | negative regulation of reactive oxygen species metabolic process(GO:2000378) |
| 0.5 | 1.0 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
| 0.5 | 1.4 | GO:0009644 | response to high light intensity(GO:0009644) |
| 0.5 | 0.5 | GO:0097049 | motor neuron apoptotic process(GO:0097049) |
| 0.5 | 4.7 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.5 | 0.9 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.5 | 1.9 | GO:0009437 | carnitine metabolic process(GO:0009437) |
| 0.5 | 1.4 | GO:0090646 | mitochondrial RNA 3'-end processing(GO:0000965) mitochondrial tRNA processing(GO:0090646) |
| 0.5 | 2.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.5 | 3.3 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.5 | 1.4 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
| 0.5 | 2.8 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
| 0.5 | 0.5 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.5 | 2.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.5 | 1.8 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.5 | 4.1 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.5 | 0.9 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.5 | 2.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.5 | 3.6 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
| 0.5 | 5.0 | GO:0045921 | positive regulation of exocytosis(GO:0045921) |
| 0.4 | 4.0 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.4 | 3.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.4 | 0.9 | GO:0014891 | striated muscle atrophy(GO:0014891) |
| 0.4 | 0.9 | GO:0070459 | prolactin secretion(GO:0070459) |
| 0.4 | 1.3 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
| 0.4 | 2.2 | GO:0010447 | response to acidic pH(GO:0010447) |
| 0.4 | 0.4 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
| 0.4 | 1.8 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.4 | 1.8 | GO:1990034 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.4 | 0.4 | GO:0030815 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) negative regulation of cAMP metabolic process(GO:0030815) |
| 0.4 | 1.3 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.4 | 0.9 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
| 0.4 | 3.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.4 | 7.0 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.4 | 4.3 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.4 | 1.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.4 | 9.5 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.4 | 0.4 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) |
| 0.4 | 1.7 | GO:1903393 | positive regulation of adherens junction organization(GO:1903393) |
| 0.4 | 0.4 | GO:0001743 | optic placode formation(GO:0001743) |
| 0.4 | 1.3 | GO:0051030 | snRNA transport(GO:0051030) |
| 0.4 | 0.9 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.4 | 6.9 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.4 | 3.9 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.4 | 0.9 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.4 | 2.6 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.4 | 14.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
| 0.4 | 1.3 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.4 | 1.7 | GO:0032530 | regulation of microvillus organization(GO:0032530) |
| 0.4 | 1.7 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
| 0.4 | 9.8 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.4 | 0.8 | GO:0009794 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.4 | 1.7 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.4 | 2.1 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.4 | 1.3 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.4 | 1.7 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 0.4 | 0.4 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.4 | 2.1 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
| 0.4 | 0.8 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.4 | 0.8 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.4 | 0.8 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
| 0.4 | 0.4 | GO:0097527 | necroptotic signaling pathway(GO:0097527) |
| 0.4 | 0.4 | GO:0007567 | parturition(GO:0007567) |
| 0.4 | 4.2 | GO:0032967 | positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.4 | 2.9 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.4 | 1.2 | GO:1901030 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901030) |
| 0.4 | 0.8 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
| 0.4 | 2.5 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.4 | 0.8 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.4 | 1.2 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
| 0.4 | 2.5 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.4 | 0.4 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.4 | 2.1 | GO:0070314 | G1 to G0 transition(GO:0070314) |
| 0.4 | 5.8 | GO:0032418 | lysosome localization(GO:0032418) |
| 0.4 | 2.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
| 0.4 | 1.6 | GO:0071498 | cellular response to fluid shear stress(GO:0071498) |
| 0.4 | 2.0 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.4 | 1.2 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.4 | 0.8 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.4 | 3.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.4 | 0.8 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
| 0.4 | 4.0 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.4 | 0.4 | GO:0045979 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
| 0.4 | 0.8 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.4 | 6.0 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.4 | 2.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.4 | 1.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.4 | 0.4 | GO:0090342 | regulation of cell aging(GO:0090342) negative regulation of cell aging(GO:0090344) |
| 0.4 | 1.2 | GO:1900365 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.4 | 0.4 | GO:0042097 | interleukin-4 biosynthetic process(GO:0042097) regulation of interleukin-4 biosynthetic process(GO:0045402) |
| 0.4 | 2.0 | GO:0000052 | citrulline metabolic process(GO:0000052) |
| 0.4 | 0.4 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
| 0.4 | 0.8 | GO:0051775 | response to redox state(GO:0051775) |
| 0.4 | 0.8 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.4 | 0.8 | GO:0061055 | myotome development(GO:0061055) |
| 0.4 | 3.2 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
| 0.4 | 1.2 | GO:2000642 | negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.4 | 2.0 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
| 0.4 | 0.4 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
| 0.4 | 1.6 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.4 | 0.8 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.4 | 1.6 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.4 | 5.4 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
| 0.4 | 1.2 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.4 | 3.9 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.4 | 1.5 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
| 0.4 | 3.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.4 | 1.2 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.4 | 1.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.4 | 1.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 0.4 | 0.4 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
| 0.4 | 10.6 | GO:0001881 | receptor recycling(GO:0001881) |
| 0.4 | 1.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.4 | 1.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.4 | 1.1 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
| 0.4 | 0.7 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.4 | 1.5 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.4 | 0.4 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
| 0.4 | 1.1 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.4 | 0.4 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.4 | 1.5 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) cellular response to lipid hydroperoxide(GO:0071449) |
| 0.4 | 1.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.4 | 1.5 | GO:0006000 | fructose metabolic process(GO:0006000) |
| 0.4 | 13.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.4 | 1.1 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.4 | 1.8 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
| 0.4 | 0.7 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
| 0.4 | 2.9 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.4 | 0.4 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
| 0.4 | 0.4 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
| 0.4 | 0.4 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
| 0.4 | 1.5 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.4 | 0.4 | GO:0042182 | ketone catabolic process(GO:0042182) |
| 0.4 | 1.4 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
| 0.4 | 1.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.4 | 1.4 | GO:0035994 | response to muscle stretch(GO:0035994) |
| 0.4 | 1.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.4 | 0.4 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
| 0.3 | 1.0 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
| 0.3 | 1.4 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.3 | 1.4 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.3 | 0.3 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.3 | 1.7 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.3 | 2.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.3 | 0.3 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.3 | 1.0 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.3 | 1.0 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.3 | 4.4 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.3 | 1.0 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.3 | 4.0 | GO:0010573 | vascular endothelial growth factor production(GO:0010573) |
| 0.3 | 1.7 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
| 0.3 | 2.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.3 | 8.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 0.3 | 1.6 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.3 | 1.0 | GO:0006986 | response to unfolded protein(GO:0006986) |
| 0.3 | 0.7 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.3 | 1.6 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
| 0.3 | 1.0 | GO:0043615 | astrocyte cell migration(GO:0043615) |
| 0.3 | 1.0 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
| 0.3 | 1.6 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.3 | 1.3 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
| 0.3 | 0.6 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.3 | 1.6 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.3 | 0.6 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.3 | 1.0 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.3 | 0.3 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.3 | 7.3 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.3 | 1.0 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.3 | 0.6 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
| 0.3 | 2.9 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.3 | 1.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 0.3 | 3.2 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.3 | 4.7 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.3 | 3.5 | GO:0044110 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
| 0.3 | 1.3 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.3 | 4.7 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
| 0.3 | 4.9 | GO:0046460 | triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.3 | 0.3 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.3 | 3.1 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.3 | 0.6 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
| 0.3 | 0.3 | GO:0015822 | ornithine transport(GO:0015822) |
| 0.3 | 0.6 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
| 0.3 | 0.3 | GO:0035844 | cloaca development(GO:0035844) |
| 0.3 | 0.6 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.3 | 1.8 | GO:2000772 | regulation of cellular senescence(GO:2000772) |
| 0.3 | 0.9 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.3 | 4.5 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.3 | 0.6 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.3 | 0.3 | GO:0014842 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
| 0.3 | 1.2 | GO:0098969 | neurotransmitter receptor transport to plasma membrane(GO:0098877) neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
| 0.3 | 1.5 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.3 | 7.9 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 0.3 | 2.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.3 | 0.9 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
| 0.3 | 16.8 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
| 0.3 | 0.6 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.3 | 1.4 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.3 | 3.7 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.3 | 1.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.3 | 2.0 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.3 | 4.2 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.3 | 1.1 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.3 | 2.0 | GO:1901898 | response to epinephrine(GO:0071871) cellular response to epinephrine stimulus(GO:0071872) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.3 | 0.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.3 | 1.1 | GO:0010998 | regulation of translational initiation by eIF2 alpha phosphorylation(GO:0010998) regulation of translational initiation in response to stress(GO:0043558) |
| 0.3 | 2.8 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.3 | 1.1 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.3 | 0.8 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.3 | 2.7 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 0.3 | 0.8 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.3 | 1.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.3 | 0.8 | GO:1905051 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.3 | 16.1 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.3 | 1.4 | GO:0060134 | prepulse inhibition(GO:0060134) |
| 0.3 | 1.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.3 | 1.4 | GO:0032782 | bile acid secretion(GO:0032782) |
| 0.3 | 10.3 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.3 | 1.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
| 0.3 | 0.3 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
| 0.3 | 19.0 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.3 | 0.8 | GO:0045006 | DNA deamination(GO:0045006) |
| 0.3 | 0.3 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.3 | 5.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.3 | 2.6 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.3 | 3.2 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.3 | 0.5 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.3 | 4.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.3 | 0.3 | GO:1903750 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.3 | 1.8 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
| 0.3 | 0.8 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.3 | 0.5 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
| 0.3 | 1.3 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
| 0.3 | 1.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.3 | 1.3 | GO:0071028 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.3 | 0.3 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.3 | 2.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.3 | 1.3 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
| 0.3 | 0.3 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 0.3 | 1.0 | GO:0015705 | iodide transport(GO:0015705) |
| 0.3 | 1.0 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
| 0.3 | 0.5 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
| 0.3 | 8.4 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
| 0.3 | 4.8 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
| 0.3 | 3.5 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
| 0.3 | 1.0 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.3 | 6.0 | GO:0034605 | cellular response to heat(GO:0034605) |
| 0.3 | 1.3 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
| 0.3 | 1.0 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.2 | 1.0 | GO:0032026 | response to magnesium ion(GO:0032026) |
| 0.2 | 7.7 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.2 | 1.0 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
| 0.2 | 1.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.2 | 2.2 | GO:0070207 | protein homotrimerization(GO:0070207) |
| 0.2 | 1.2 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.2 | 1.5 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
| 0.2 | 0.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.2 | 0.7 | GO:0048069 | eye pigmentation(GO:0048069) |
| 0.2 | 0.5 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
| 0.2 | 9.3 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
| 0.2 | 3.8 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.2 | 0.5 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
| 0.2 | 1.6 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.2 | 0.9 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 0.2 | 1.2 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.2 | 0.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.2 | 1.8 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.2 | 2.5 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.2 | 1.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.2 | 0.7 | GO:0042402 | amine catabolic process(GO:0009310) cellular biogenic amine catabolic process(GO:0042402) |
| 0.2 | 0.7 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.2 | 0.9 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 0.2 | 1.5 | GO:0005980 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.2 | 0.6 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
| 0.2 | 1.9 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.2 | 0.4 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.2 | 2.4 | GO:0097576 | vacuole fusion(GO:0097576) |
| 0.2 | 0.6 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.2 | 0.2 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 0.2 | 2.3 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.2 | 1.9 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
| 0.2 | 0.4 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 0.2 | 1.2 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.2 | 2.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
| 0.2 | 0.6 | GO:0035878 | nail development(GO:0035878) |
| 0.2 | 1.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.2 | 0.8 | GO:0061756 | leukocyte tethering or rolling(GO:0050901) leukocyte adhesion to vascular endothelial cell(GO:0061756) |
| 0.2 | 0.2 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.2 | 4.2 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.2 | 0.2 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.2 | 1.2 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
| 0.2 | 0.6 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.2 | 1.2 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.2 | 0.4 | GO:0030947 | regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030947) |
| 0.2 | 0.6 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.2 | 1.7 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
| 0.2 | 1.7 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.2 | 0.6 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
| 0.2 | 2.5 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.2 | 9.8 | GO:0030032 | lamellipodium assembly(GO:0030032) |
| 0.2 | 0.4 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
| 0.2 | 0.2 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.2 | 1.9 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.2 | 0.8 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.2 | 0.9 | GO:0071624 | positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.2 | 0.6 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.2 | 0.4 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
| 0.2 | 1.7 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.2 | 0.4 | GO:0000448 | cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000448) |
| 0.2 | 0.6 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
| 0.2 | 0.7 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
| 0.2 | 0.6 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.2 | 0.2 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.2 | 0.4 | GO:0042045 | epithelial fluid transport(GO:0042045) |
| 0.2 | 1.5 | GO:0046958 | nonassociative learning(GO:0046958) |
| 0.2 | 0.7 | GO:0010745 | regulation of macrophage derived foam cell differentiation(GO:0010743) negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.2 | 1.1 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.2 | 0.2 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.2 | 0.4 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.2 | 0.2 | GO:0046684 | response to insecticide(GO:0017085) response to pyrethroid(GO:0046684) |
| 0.2 | 0.2 | GO:0019883 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous antigen(GO:0019883) |
| 0.2 | 0.2 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 0.2 | 0.4 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.2 | 1.4 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
| 0.2 | 0.2 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) regulation of MHC class II biosynthetic process(GO:0045346) negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.2 | 0.4 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
| 0.2 | 1.6 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.2 | 0.4 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) |
| 0.2 | 2.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 0.2 | 0.9 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.2 | 3.0 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.2 | 3.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.2 | 2.9 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.2 | 1.0 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.2 | 1.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 | 0.5 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.2 | 5.8 | GO:0035456 | response to interferon-beta(GO:0035456) |
| 0.2 | 0.7 | GO:0009212 | dTTP biosynthetic process(GO:0006235) deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) dTTP metabolic process(GO:0046075) |
| 0.2 | 1.2 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
| 0.2 | 0.5 | GO:0015677 | copper ion import(GO:0015677) |
| 0.2 | 1.3 | GO:2000291 | regulation of myoblast proliferation(GO:2000291) |
| 0.2 | 1.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.2 | 0.7 | GO:0050812 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.2 | 0.8 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.2 | 0.7 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.2 | 3.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
| 0.2 | 0.5 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.2 | 0.3 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
| 0.2 | 0.2 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.2 | 0.5 | GO:0015882 | L-ascorbic acid transport(GO:0015882) L-ascorbic acid metabolic process(GO:0019852) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.2 | 1.6 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.2 | 1.6 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.2 | 1.6 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
| 0.2 | 0.3 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 0.2 | 0.5 | GO:0035902 | response to immobilization stress(GO:0035902) |
| 0.2 | 3.4 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
| 0.2 | 0.3 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.2 | 1.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
| 0.2 | 0.9 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 0.2 | 0.3 | GO:0043536 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.2 | 1.5 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
| 0.2 | 0.5 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.2 | 2.1 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
| 0.1 | 0.3 | GO:0015817 | histidine transport(GO:0015817) |
| 0.1 | 0.3 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
| 0.1 | 0.1 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.1 | 0.1 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.1 | 0.1 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
| 0.1 | 0.7 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.1 | 6.8 | GO:0032543 | mitochondrial translation(GO:0032543) |
| 0.1 | 1.7 | GO:0050810 | regulation of steroid biosynthetic process(GO:0050810) |
| 0.1 | 0.3 | GO:0090343 | positive regulation of cell aging(GO:0090343) positive regulation of cellular senescence(GO:2000774) |
| 0.1 | 0.4 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
| 0.1 | 0.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.1 | 0.4 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 0.1 | 2.0 | GO:0008210 | estrogen metabolic process(GO:0008210) |
| 0.1 | 0.6 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 | 0.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.1 | 0.7 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
| 0.1 | 2.9 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
| 0.1 | 0.4 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
| 0.1 | 0.3 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 0.1 | 0.8 | GO:0034427 | nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.1 | 0.1 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.1 | 0.3 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 0.1 | 0.3 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
| 0.1 | 1.2 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.1 | 0.8 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 0.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.1 | 1.5 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
| 0.1 | 0.7 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.1 | 0.8 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.1 | 0.3 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
| 0.1 | 0.7 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
| 0.1 | 1.9 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.1 | 1.7 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.1 | 2.0 | GO:0006744 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.1 | 0.3 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.1 | 0.1 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.1 | 0.5 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
| 0.1 | 0.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.1 | 0.3 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.1 | 1.2 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
| 0.1 | 1.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.1 | 0.5 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 | 0.4 | GO:0006953 | acute-phase response(GO:0006953) |
| 0.1 | 7.2 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 | 1.3 | GO:0009268 | response to pH(GO:0009268) |
| 0.1 | 0.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
| 0.1 | 0.4 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
| 0.1 | 0.5 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.1 | 1.7 | GO:0051647 | nucleus localization(GO:0051647) |
| 0.1 | 0.7 | GO:0097300 | programmed necrotic cell death(GO:0097300) |
| 0.1 | 0.4 | GO:0002544 | chronic inflammatory response(GO:0002544) |
| 0.1 | 0.2 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 3.2 | GO:0043038 | amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
| 0.1 | 0.4 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.1 | 1.6 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 | 2.7 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.1 | 0.5 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 | 0.6 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.1 | 0.5 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.1 | 0.7 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
| 0.1 | 0.5 | GO:0014823 | response to activity(GO:0014823) |
| 0.1 | 1.0 | GO:0046051 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
| 0.1 | 0.3 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
| 0.1 | 0.5 | GO:0009148 | pyrimidine nucleoside triphosphate biosynthetic process(GO:0009148) |
| 0.1 | 0.1 | GO:0046098 | guanine metabolic process(GO:0046098) |
| 0.1 | 2.0 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
| 0.1 | 0.2 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
| 0.1 | 1.1 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
| 0.1 | 0.1 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.1 | 0.4 | GO:0006801 | superoxide metabolic process(GO:0006801) |
| 0.1 | 0.9 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 0.1 | 0.1 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.1 | 0.6 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
| 0.1 | 0.6 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.1 | 3.8 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
| 0.1 | 0.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.1 | 2.0 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.1 | 0.2 | GO:1903036 | positive regulation of response to wounding(GO:1903036) |
| 0.1 | 1.7 | GO:0042308 | negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein import(GO:1904590) |
| 0.1 | 0.1 | GO:1902047 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.1 | 0.2 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.1 | 0.5 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
| 0.1 | 0.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 0.1 | 0.3 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) |
| 0.1 | 0.4 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
| 0.1 | 0.1 | GO:0051593 | response to folic acid(GO:0051593) |
| 0.1 | 0.7 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 | 0.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.1 | 1.0 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.1 | 1.2 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.1 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.1 | 1.2 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.1 | 1.5 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) positive regulation of mRNA catabolic process(GO:0061014) |
| 0.1 | 1.5 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.1 | 0.4 | GO:0030641 | regulation of cellular pH(GO:0030641) |
| 0.1 | 0.3 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 1.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.1 | 0.9 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
| 0.1 | 0.2 | GO:0043084 | penile erection(GO:0043084) |
| 0.1 | 0.4 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 | 1.5 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 | 0.1 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.1 | 0.2 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.1 | 0.3 | GO:1900368 | regulation of RNA interference(GO:1900368) |
| 0.1 | 0.4 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.1 | 0.3 | GO:0046104 | thymidine metabolic process(GO:0046104) |
| 0.1 | 0.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 | 0.8 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.1 | 0.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.1 | 0.4 | GO:0015858 | nucleoside transport(GO:0015858) |
| 0.1 | 0.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.1 | 0.2 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
| 0.1 | 0.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 | 1.0 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
| 0.1 | 0.4 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.1 | 0.3 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.1 | 1.1 | GO:0042990 | regulation of transcription factor import into nucleus(GO:0042990) |
| 0.1 | 1.6 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.1 | 0.6 | GO:0071451 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 0.1 | 0.2 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
| 0.1 | 0.4 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.1 | 0.7 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
| 0.1 | 0.1 | GO:1904429 | regulation of t-circle formation(GO:1904429) negative regulation of t-circle formation(GO:1904430) |
| 0.1 | 0.1 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.1 | 0.5 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
| 0.1 | 0.4 | GO:0001976 | neurological system process involved in regulation of systemic arterial blood pressure(GO:0001976) |
| 0.1 | 0.1 | GO:0035106 | operant conditioning(GO:0035106) |
| 0.1 | 0.1 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
| 0.1 | 1.5 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 | 1.4 | GO:0000045 | autophagosome assembly(GO:0000045) |
| 0.1 | 2.9 | GO:0007416 | synapse assembly(GO:0007416) |
| 0.1 | 0.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.1 | 0.1 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
| 0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
| 0.1 | 0.1 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
| 0.1 | 0.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.1 | 0.7 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.1 | 0.1 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
| 0.1 | 0.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 | 0.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.1 | 1.6 | GO:0008542 | visual learning(GO:0008542) |
| 0.1 | 0.3 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
| 0.1 | 0.2 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
| 0.1 | 0.2 | GO:0036089 | cleavage furrow formation(GO:0036089) |
| 0.1 | 0.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 | 0.6 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 | 0.3 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
| 0.1 | 0.1 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 | 0.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 | 0.5 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.1 | 0.5 | GO:0033622 | integrin activation(GO:0033622) |
| 0.1 | 0.1 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 | 0.3 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
| 0.1 | 0.6 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.0 | 0.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.0 | 0.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
| 0.0 | 0.3 | GO:0001505 | regulation of neurotransmitter levels(GO:0001505) |
| 0.0 | 0.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.0 | 0.4 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
| 0.0 | 0.1 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
| 0.0 | 0.1 | GO:0032376 | positive regulation of sterol transport(GO:0032373) positive regulation of cholesterol transport(GO:0032376) |
| 0.0 | 0.2 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.0 | 3.4 | GO:0006836 | neurotransmitter transport(GO:0006836) |
| 0.0 | 0.3 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.0 | 0.1 | GO:0060745 | mammary gland branching involved in pregnancy(GO:0060745) |
| 0.0 | 0.3 | GO:0048713 | regulation of oligodendrocyte differentiation(GO:0048713) |
| 0.0 | 1.2 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.0 | 0.1 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.0 | 1.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.0 | 3.1 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
| 0.0 | 0.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.0 | 0.1 | GO:0010878 | cholesterol storage(GO:0010878) |
| 0.0 | 0.1 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.0 | 0.2 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.0 | 3.6 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
| 0.0 | 0.2 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
| 0.0 | 0.1 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.0 | 0.2 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.0 | 0.1 | GO:0090283 | protein glycosylation in Golgi(GO:0033578) regulation of protein glycosylation in Golgi(GO:0090283) negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.0 | 0.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
| 0.0 | 0.1 | GO:0048209 | regulation of vesicle targeting, to, from or within Golgi(GO:0048209) |
| 0.0 | 0.0 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
| 0.0 | 1.0 | GO:0006821 | chloride transport(GO:0006821) |
| 0.0 | 0.0 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.0 | 0.1 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) negative regulation of interferon-beta production(GO:0032688) |
| 0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
| 0.0 | 0.1 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 0.0 | 0.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.0 | 0.2 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) vesicle uncoating(GO:0072319) |
| 0.0 | 0.3 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 | 0.2 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.0 | 0.1 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.0 | 0.1 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.0 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
| 0.0 | 0.1 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.0 | 0.0 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.0 | 0.7 | GO:0042073 | intraciliary transport(GO:0042073) |
| 0.0 | 0.1 | GO:0019882 | antigen processing and presentation(GO:0019882) |
| 0.0 | 0.0 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
| 0.0 | 0.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 | 0.2 | GO:0071806 | intracellular protein transmembrane transport(GO:0065002) protein transmembrane transport(GO:0071806) |
| 0.0 | 0.1 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.0 | 0.0 | GO:0001840 | neural plate development(GO:0001840) |
| 0.0 | 0.1 | GO:0001964 | startle response(GO:0001964) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.2 | 15.6 | GO:0071953 | elastic fiber(GO:0071953) |
| 4.9 | 14.8 | GO:0098855 | HCN channel complex(GO:0098855) |
| 4.5 | 13.6 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
| 4.5 | 13.5 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 4.3 | 13.0 | GO:0045160 | myosin I complex(GO:0045160) |
| 4.0 | 12.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 3.7 | 7.5 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
| 3.6 | 14.4 | GO:0043511 | inhibin complex(GO:0043511) |
| 3.5 | 17.7 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 3.4 | 20.5 | GO:0016011 | dystroglycan complex(GO:0016011) |
| 3.0 | 12.1 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
| 3.0 | 3.0 | GO:1902737 | dendritic filopodium(GO:1902737) |
| 3.0 | 8.9 | GO:0072534 | perineuronal net(GO:0072534) |
| 2.9 | 14.6 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
| 2.9 | 8.7 | GO:0038045 | large latent transforming growth factor-beta complex(GO:0038045) |
| 2.8 | 8.5 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 2.8 | 8.4 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 2.8 | 11.1 | GO:0014802 | terminal cisterna(GO:0014802) |
| 2.6 | 10.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 2.6 | 15.6 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
| 2.5 | 12.7 | GO:1990246 | uniplex complex(GO:1990246) |
| 2.5 | 2.5 | GO:0097542 | ciliary tip(GO:0097542) |
| 2.5 | 14.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 2.4 | 14.1 | GO:0035976 | AP1 complex(GO:0035976) |
| 2.2 | 2.2 | GO:0005594 | FACIT collagen trimer(GO:0005593) collagen type IX trimer(GO:0005594) |
| 2.1 | 10.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 2.1 | 6.2 | GO:0048179 | activin receptor complex(GO:0048179) |
| 2.0 | 13.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 2.0 | 7.9 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
| 1.9 | 5.7 | GO:0000802 | transverse filament(GO:0000802) |
| 1.9 | 11.4 | GO:0008091 | spectrin(GO:0008091) |
| 1.8 | 1.8 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
| 1.8 | 20.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 1.8 | 25.3 | GO:0043083 | synaptic cleft(GO:0043083) |
| 1.8 | 34.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 1.8 | 21.5 | GO:0044327 | dendritic spine head(GO:0044327) |
| 1.7 | 12.2 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 1.7 | 5.0 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 1.6 | 6.5 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 1.6 | 3.2 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 1.6 | 11.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 1.6 | 1.6 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 1.5 | 6.2 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 1.5 | 1.5 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 1.5 | 6.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 1.5 | 1.5 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
| 1.5 | 4.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 1.5 | 13.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 1.4 | 18.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 1.4 | 5.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 1.4 | 4.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 1.4 | 4.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 1.4 | 13.8 | GO:0045298 | tubulin complex(GO:0045298) |
| 1.4 | 12.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
| 1.4 | 9.5 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
| 1.3 | 4.0 | GO:0005584 | collagen type I trimer(GO:0005584) |
| 1.3 | 1.3 | GO:1990415 | Pex17p-Pex14p docking complex(GO:1990415) peroxisomal importomer complex(GO:1990429) |
| 1.3 | 3.9 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 1.3 | 3.9 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 1.3 | 27.3 | GO:0005581 | collagen trimer(GO:0005581) |
| 1.3 | 3.9 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 1.3 | 5.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 1.3 | 3.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 1.2 | 5.0 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 1.2 | 6.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
| 1.2 | 4.9 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
| 1.2 | 1.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 1.2 | 4.7 | GO:0097574 | lateral part of cell(GO:0097574) basolateral part of cell(GO:1990794) rod bipolar cell terminal bouton(GO:1990795) |
| 1.2 | 11.6 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
| 1.2 | 2.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 1.1 | 6.8 | GO:0000322 | storage vacuole(GO:0000322) |
| 1.1 | 4.5 | GO:0032280 | symmetric synapse(GO:0032280) |
| 1.1 | 3.4 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
| 1.1 | 1.1 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
| 1.1 | 17.5 | GO:0005614 | interstitial matrix(GO:0005614) |
| 1.1 | 3.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 1.1 | 16.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 1.1 | 2.2 | GO:0098842 | postsynaptic early endosome(GO:0098842) |
| 1.1 | 2.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 1.1 | 4.3 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
| 1.0 | 17.3 | GO:0000124 | SAGA complex(GO:0000124) |
| 1.0 | 4.1 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 1.0 | 21.3 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 1.0 | 5.0 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
| 1.0 | 13.1 | GO:0097449 | astrocyte projection(GO:0097449) |
| 1.0 | 5.0 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 1.0 | 1.0 | GO:0019034 | viral replication complex(GO:0019034) |
| 1.0 | 19.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 1.0 | 2.9 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 0.9 | 6.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.9 | 14.1 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
| 0.9 | 3.8 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.9 | 3.7 | GO:1990769 | proximal neuron projection(GO:1990769) |
| 0.9 | 1.8 | GO:0032437 | cuticular plate(GO:0032437) |
| 0.9 | 17.2 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.9 | 7.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.9 | 10.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.9 | 12.3 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
| 0.9 | 1.8 | GO:0099569 | presynaptic cytoskeleton(GO:0099569) |
| 0.9 | 7.8 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 0.9 | 10.4 | GO:0043203 | axon hillock(GO:0043203) |
| 0.8 | 11.9 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.8 | 4.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.8 | 3.4 | GO:0071797 | LUBAC complex(GO:0071797) |
| 0.8 | 10.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.8 | 5.7 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.8 | 8.2 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.8 | 6.5 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
| 0.8 | 0.8 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.8 | 4.0 | GO:0044316 | cone cell pedicle(GO:0044316) |
| 0.8 | 8.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.8 | 6.4 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
| 0.8 | 4.8 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.8 | 41.1 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.8 | 14.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
| 0.8 | 3.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.8 | 5.4 | GO:0005638 | lamin filament(GO:0005638) |
| 0.8 | 0.8 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 0.7 | 3.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.7 | 6.7 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.7 | 5.9 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.7 | 2.9 | GO:0005745 | m-AAA complex(GO:0005745) |
| 0.7 | 2.9 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.7 | 1.5 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.7 | 10.2 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.7 | 5.0 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
| 0.7 | 2.8 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.7 | 7.1 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.7 | 1.4 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
| 0.7 | 6.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.7 | 2.7 | GO:0031430 | M band(GO:0031430) |
| 0.7 | 2.0 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.7 | 8.8 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.7 | 4.0 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.7 | 2.7 | GO:0030891 | VCB complex(GO:0030891) |
| 0.7 | 4.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.7 | 4.7 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.7 | 13.3 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.7 | 2.0 | GO:0032127 | dense core granule membrane(GO:0032127) |
| 0.7 | 23.9 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.7 | 8.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.7 | 2.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.6 | 5.8 | GO:0031045 | dense core granule(GO:0031045) |
| 0.6 | 1.9 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.6 | 9.7 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
| 0.6 | 8.4 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.6 | 8.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.6 | 7.6 | GO:0042581 | specific granule(GO:0042581) |
| 0.6 | 1.9 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.6 | 2.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.6 | 3.1 | GO:1990745 | EARP complex(GO:1990745) |
| 0.6 | 0.6 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
| 0.6 | 2.4 | GO:1990590 | ATF1-ATF4 transcription factor complex(GO:1990590) |
| 0.6 | 4.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.6 | 9.6 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
| 0.6 | 3.0 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.6 | 6.6 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.6 | 20.2 | GO:0044298 | cell body membrane(GO:0044298) |
| 0.6 | 4.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.6 | 13.9 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.6 | 2.9 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.6 | 4.0 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.6 | 59.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
| 0.6 | 8.5 | GO:0005776 | autophagosome(GO:0005776) |
| 0.6 | 15.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.5 | 1.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.5 | 0.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.5 | 4.4 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.5 | 3.3 | GO:0071203 | WASH complex(GO:0071203) |
| 0.5 | 1.6 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.5 | 5.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.5 | 2.1 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.5 | 2.6 | GO:0033270 | paranode region of axon(GO:0033270) |
| 0.5 | 1.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.5 | 2.6 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.5 | 12.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.5 | 2.6 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
| 0.5 | 16.5 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.5 | 11.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.5 | 1.5 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.5 | 1.5 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.5 | 1.0 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.5 | 3.5 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.5 | 0.5 | GO:0001651 | dense fibrillar component(GO:0001651) |
| 0.5 | 16.1 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.5 | 2.5 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.5 | 2.9 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.5 | 1.0 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.5 | 4.4 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
| 0.5 | 1.5 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.5 | 4.8 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.5 | 8.7 | GO:0016528 | sarcoplasm(GO:0016528) |
| 0.5 | 112.7 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.5 | 2.4 | GO:0097361 | CIA complex(GO:0097361) |
| 0.5 | 3.8 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.5 | 3.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
| 0.5 | 1.4 | GO:0032009 | early phagosome(GO:0032009) |
| 0.5 | 1.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.5 | 5.1 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.5 | 7.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.5 | 0.5 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.5 | 4.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.4 | 94.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.4 | 17.7 | GO:0005770 | late endosome(GO:0005770) |
| 0.4 | 4.4 | GO:0030914 | STAGA complex(GO:0030914) |
| 0.4 | 2.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.4 | 1.8 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.4 | 0.4 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.4 | 6.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.4 | 2.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
| 0.4 | 1.3 | GO:0000811 | GINS complex(GO:0000811) |
| 0.4 | 6.7 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.4 | 1.3 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.4 | 5.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.4 | 0.4 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
| 0.4 | 0.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.4 | 2.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.4 | 9.5 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.4 | 12.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.4 | 0.4 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.4 | 11.8 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.4 | 1.2 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
| 0.4 | 0.4 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.4 | 3.4 | GO:0032300 | mismatch repair complex(GO:0032300) |
| 0.4 | 9.5 | GO:0016235 | aggresome(GO:0016235) |
| 0.4 | 2.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 0.4 | 22.6 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.4 | 1.9 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
| 0.4 | 4.8 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.4 | 12.2 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.4 | 12.9 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.4 | 4.7 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
| 0.4 | 1.8 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.4 | 5.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.4 | 2.5 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.4 | 1.1 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.4 | 1.8 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.4 | 13.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.3 | 5.2 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.3 | 3.5 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.3 | 1.4 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.3 | 5.9 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.3 | 1.7 | GO:0042599 | lamellar body(GO:0042599) |
| 0.3 | 8.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.3 | 2.7 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.3 | 3.4 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.3 | 1.0 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.3 | 5.0 | GO:0042555 | MCM complex(GO:0042555) |
| 0.3 | 26.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.3 | 0.3 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
| 0.3 | 1.0 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.3 | 1.0 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.3 | 43.1 | GO:0070382 | exocytic vesicle(GO:0070382) |
| 0.3 | 2.2 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.3 | 2.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.3 | 20.7 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.3 | 1.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.3 | 0.9 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.3 | 19.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.3 | 4.9 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
| 0.3 | 1.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.3 | 1.5 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.3 | 0.6 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
| 0.3 | 10.5 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.3 | 1.2 | GO:0005921 | gap junction(GO:0005921) |
| 0.3 | 64.3 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.3 | 0.6 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.3 | 19.4 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
| 0.3 | 0.6 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
| 0.3 | 2.9 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.3 | 2.0 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.3 | 1.1 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.3 | 2.5 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.3 | 0.3 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.3 | 1.9 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 0.3 | 89.4 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
| 0.3 | 2.7 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.3 | 7.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.3 | 0.8 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
| 0.3 | 1.1 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.3 | 2.4 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.3 | 0.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.3 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.3 | 5.1 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.2 | 0.7 | GO:0055087 | Ski complex(GO:0055087) |
| 0.2 | 13.8 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.2 | 22.8 | GO:0005802 | trans-Golgi network(GO:0005802) |
| 0.2 | 2.7 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.2 | 1.2 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.2 | 5.5 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.2 | 5.7 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.2 | 4.0 | GO:0000145 | exocyst(GO:0000145) |
| 0.2 | 0.5 | GO:1902636 | kinocilium(GO:0060091) kinociliary basal body(GO:1902636) |
| 0.2 | 7.5 | GO:0030139 | endocytic vesicle(GO:0030139) |
| 0.2 | 4.2 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.2 | 16.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.2 | 3.9 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
| 0.2 | 1.5 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.2 | 1.1 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.2 | 13.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.2 | 2.9 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.2 | 1.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
| 0.2 | 0.4 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.2 | 1.0 | GO:0043198 | dendritic shaft(GO:0043198) |
| 0.2 | 10.2 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.2 | 2.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.2 | 2.3 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.2 | 6.1 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.2 | 67.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.2 | 3.6 | GO:0030018 | Z disc(GO:0030018) |
| 0.2 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.2 | 5.6 | GO:0005903 | brush border(GO:0005903) |
| 0.2 | 1.0 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.2 | 2.1 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.2 | 1.3 | GO:0036452 | ESCRT complex(GO:0036452) |
| 0.2 | 0.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.2 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.2 | 1.6 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.2 | 1.4 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.2 | 0.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.2 | 0.2 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.2 | 2.3 | GO:0042611 | MHC protein complex(GO:0042611) |
| 0.2 | 0.7 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.2 | 34.3 | GO:0097060 | synaptic membrane(GO:0097060) |
| 0.2 | 1.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.2 | 1.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.2 | 3.8 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.2 | 0.3 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.2 | 393.3 | GO:0016021 | integral component of membrane(GO:0016021) |
| 0.2 | 1.4 | GO:0036038 | MKS complex(GO:0036038) |
| 0.2 | 1.1 | GO:0035145 | exon-exon junction complex(GO:0035145) |
| 0.2 | 19.7 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.1 | 1.3 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.1 | 0.9 | GO:1990393 | 3M complex(GO:1990393) |
| 0.1 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.1 | 0.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.1 | 1.8 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 0.4 | GO:0030315 | T-tubule(GO:0030315) |
| 0.1 | 1.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.1 | 0.3 | GO:0097433 | dense body(GO:0097433) |
| 0.1 | 0.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 2.9 | GO:0097546 | ciliary base(GO:0097546) |
| 0.1 | 1.3 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.1 | 9.4 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 6.1 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.1 | 2.9 | GO:0044306 | neuron projection terminus(GO:0044306) |
| 0.1 | 2.5 | GO:0030016 | myofibril(GO:0030016) |
| 0.1 | 4.5 | GO:0001726 | ruffle(GO:0001726) |
| 0.1 | 0.5 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.1 | 2.4 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.1 | 0.8 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.1 | 1.2 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.1 | 1.0 | GO:0022626 | cytosolic ribosome(GO:0022626) |
| 0.1 | 0.9 | GO:0005840 | ribosome(GO:0005840) |
| 0.1 | 0.4 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.1 | 0.8 | GO:0012506 | vesicle membrane(GO:0012506) |
| 0.1 | 0.4 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.1 | 0.5 | GO:0097227 | sperm annulus(GO:0097227) |
| 0.1 | 3.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.1 | 0.7 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.1 | 2.1 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.1 | 1.1 | GO:0043235 | receptor complex(GO:0043235) |
| 0.1 | 12.8 | GO:0044429 | mitochondrial part(GO:0044429) |
| 0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.1 | 2.5 | GO:0005769 | early endosome(GO:0005769) |
| 0.1 | 0.8 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 1.5 | GO:0031252 | cell leading edge(GO:0031252) |
| 0.1 | 0.6 | GO:0044440 | endosomal part(GO:0044440) |
| 0.1 | 0.2 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 0.1 | 0.4 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
| 0.1 | 0.7 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
| 0.1 | 2.3 | GO:0005811 | lipid particle(GO:0005811) |
| 0.1 | 32.7 | GO:0005615 | extracellular space(GO:0005615) |
| 0.1 | 0.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.1 | 50.6 | GO:0005739 | mitochondrion(GO:0005739) |
| 0.1 | 2.2 | GO:0030424 | axon(GO:0030424) |
| 0.1 | 0.1 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.1 | 0.3 | GO:0005773 | vacuole(GO:0005773) |
| 0.1 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.1 | 3.9 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.1 | 0.7 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.1 | 6.2 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.1 | 0.5 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.0 | 0.1 | GO:0045180 | basal cortex(GO:0045180) |
| 0.0 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.0 | 0.6 | GO:0030133 | transport vesicle(GO:0030133) |
| 0.0 | 2.3 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.0 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.0 | 1.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.0 | 0.1 | GO:0016459 | myosin complex(GO:0016459) |
| 0.0 | 0.1 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.0 | 0.0 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.0 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.6 | 16.9 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 4.8 | 14.3 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 4.6 | 18.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 4.5 | 13.5 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
| 4.5 | 17.9 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 4.3 | 12.8 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 4.0 | 12.1 | GO:0046911 | hydroxyapatite binding(GO:0046848) metal chelating activity(GO:0046911) phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 4.0 | 12.0 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) |
| 3.9 | 19.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
| 3.7 | 18.4 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 3.7 | 22.0 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 3.4 | 10.3 | GO:0002153 | steroid receptor RNA activator RNA binding(GO:0002153) |
| 3.4 | 17.1 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 3.4 | 3.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 3.2 | 9.7 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 3.2 | 12.9 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 3.2 | 9.6 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 2.9 | 17.7 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 2.9 | 14.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 2.8 | 25.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
| 2.8 | 16.9 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 2.6 | 18.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 2.6 | 10.2 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
| 2.4 | 7.3 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 2.4 | 7.3 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
| 2.4 | 31.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 2.3 | 11.5 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 2.3 | 11.4 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 2.2 | 6.7 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 2.2 | 8.8 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
| 2.2 | 6.6 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 2.2 | 8.7 | GO:0019962 | interferon receptor activity(GO:0004904) type I interferon receptor activity(GO:0004905) type I interferon binding(GO:0019962) |
| 2.2 | 8.7 | GO:0050436 | microfibril binding(GO:0050436) |
| 2.2 | 8.7 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 2.2 | 6.5 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 2.1 | 8.5 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 2.1 | 8.5 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 2.1 | 10.6 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
| 2.1 | 12.7 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 2.1 | 6.3 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 2.1 | 8.4 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 2.1 | 16.8 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 2.0 | 12.2 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 2.0 | 6.0 | GO:0015228 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
| 2.0 | 2.0 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 1.9 | 5.8 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
| 1.9 | 7.7 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
| 1.9 | 7.6 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
| 1.9 | 5.7 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
| 1.9 | 3.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
| 1.9 | 5.6 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 1.8 | 1.8 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) alpha-1B adrenergic receptor binding(GO:0031692) follicle-stimulating hormone receptor binding(GO:0031762) |
| 1.8 | 7.4 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 1.8 | 16.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 1.8 | 7.2 | GO:0070012 | oligopeptidase activity(GO:0070012) |
| 1.8 | 14.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 1.8 | 21.2 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
| 1.7 | 5.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 1.7 | 6.9 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 1.7 | 6.9 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
| 1.7 | 5.1 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 1.7 | 8.5 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 1.7 | 11.7 | GO:0099609 | microtubule lateral binding(GO:0099609) |
| 1.7 | 5.0 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 1.7 | 29.8 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 1.7 | 9.9 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 1.6 | 4.9 | GO:0036361 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 1.6 | 3.3 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
| 1.6 | 3.2 | GO:0005110 | frizzled-2 binding(GO:0005110) |
| 1.6 | 3.2 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 1.6 | 4.8 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 1.6 | 6.4 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 1.6 | 11.2 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 1.6 | 14.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 1.6 | 4.8 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
| 1.6 | 7.9 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
| 1.6 | 9.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
| 1.5 | 26.2 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 1.5 | 10.7 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 1.5 | 9.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 1.5 | 4.6 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
| 1.5 | 6.1 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 1.5 | 6.1 | GO:0008061 | chitin binding(GO:0008061) |
| 1.5 | 12.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 1.5 | 4.5 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 1.5 | 3.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 1.5 | 3.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 1.5 | 4.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 1.5 | 7.4 | GO:0005534 | galactose binding(GO:0005534) |
| 1.5 | 5.9 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
| 1.5 | 5.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 1.5 | 4.4 | GO:0032142 | single guanine insertion binding(GO:0032142) |
| 1.4 | 5.7 | GO:0048495 | Roundabout binding(GO:0048495) |
| 1.4 | 1.4 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 1.4 | 4.2 | GO:0015232 | heme transporter activity(GO:0015232) |
| 1.4 | 2.8 | GO:0015099 | nickel cation transmembrane transporter activity(GO:0015099) |
| 1.4 | 8.4 | GO:0019864 | immunoglobulin receptor activity(GO:0019763) IgG binding(GO:0019864) |
| 1.4 | 1.4 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
| 1.4 | 5.5 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 1.4 | 8.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 1.4 | 6.9 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 1.4 | 4.1 | GO:0030957 | Tat protein binding(GO:0030957) |
| 1.4 | 5.5 | GO:0035473 | lipase binding(GO:0035473) |
| 1.4 | 11.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 1.4 | 5.5 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 1.4 | 13.6 | GO:0008556 | sodium:potassium-exchanging ATPase activity(GO:0005391) potassium-transporting ATPase activity(GO:0008556) |
| 1.4 | 5.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 1.3 | 8.0 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 1.3 | 5.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
| 1.3 | 7.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 1.3 | 3.9 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
| 1.3 | 7.8 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 1.3 | 3.9 | GO:0005118 | sevenless binding(GO:0005118) |
| 1.3 | 3.9 | GO:0036004 | GAF domain binding(GO:0036004) |
| 1.3 | 5.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 1.3 | 5.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 1.3 | 3.8 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 1.3 | 8.9 | GO:0070697 | activin receptor binding(GO:0070697) |
| 1.3 | 3.8 | GO:0009374 | biotin binding(GO:0009374) |
| 1.3 | 18.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 1.3 | 40.2 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 1.2 | 5.0 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 1.2 | 7.5 | GO:0008518 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
| 1.2 | 6.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 1.2 | 5.0 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
| 1.2 | 7.4 | GO:0043426 | MRF binding(GO:0043426) |
| 1.2 | 4.9 | GO:0016230 | sphingomyelin phosphodiesterase activator activity(GO:0016230) |
| 1.2 | 6.1 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 1.2 | 9.8 | GO:0031811 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
| 1.2 | 4.9 | GO:0004064 | arylesterase activity(GO:0004064) |
| 1.2 | 3.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 1.2 | 21.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 1.2 | 2.4 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
| 1.2 | 4.8 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
| 1.2 | 22.7 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 1.2 | 10.7 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 1.2 | 10.7 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 1.2 | 2.4 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 1.2 | 2.4 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 1.2 | 8.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 1.2 | 6.9 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 1.2 | 2.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 1.2 | 3.5 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 1.1 | 2.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 1.1 | 9.0 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) |
| 1.1 | 6.7 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 1.1 | 4.5 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
| 1.1 | 1.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 1.1 | 6.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 1.1 | 3.3 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 1.1 | 11.1 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 1.1 | 21.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 1.1 | 7.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 1.1 | 5.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 1.1 | 3.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
| 1.1 | 4.3 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
| 1.1 | 11.9 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 1.1 | 11.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 1.1 | 1.1 | GO:0001007 | transcription factor activity, RNA polymerase III transcription factor binding(GO:0001007) |
| 1.1 | 7.5 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 1.1 | 2.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 1.1 | 7.5 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 1.1 | 1.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
| 1.1 | 3.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 1.1 | 3.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 1.1 | 3.2 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
| 1.0 | 4.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 1.0 | 1.0 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 1.0 | 5.2 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 1.0 | 10.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 1.0 | 4.1 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 1.0 | 23.4 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 1.0 | 38.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 1.0 | 7.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 1.0 | 4.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 1.0 | 5.0 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 1.0 | 13.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 1.0 | 3.9 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 1.0 | 3.9 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 1.0 | 3.9 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 1.0 | 7.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 1.0 | 6.8 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 1.0 | 3.9 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 1.0 | 2.9 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.9 | 0.9 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.9 | 0.9 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
| 0.9 | 12.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
| 0.9 | 2.8 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.9 | 2.8 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.9 | 3.7 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
| 0.9 | 2.8 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
| 0.9 | 2.8 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.9 | 3.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.9 | 2.8 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
| 0.9 | 8.3 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.9 | 2.7 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
| 0.9 | 4.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
| 0.9 | 34.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.9 | 23.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.9 | 7.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.9 | 10.7 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
| 0.9 | 3.6 | GO:0004096 | catalase activity(GO:0004096) |
| 0.9 | 2.7 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.9 | 13.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.9 | 3.5 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.9 | 3.5 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.9 | 3.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.9 | 0.9 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 0.9 | 8.7 | GO:0008430 | selenium binding(GO:0008430) |
| 0.9 | 3.5 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.9 | 1.7 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 0.9 | 3.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.9 | 17.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.8 | 3.4 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.8 | 49.1 | GO:0005179 | hormone activity(GO:0005179) |
| 0.8 | 1.7 | GO:0055102 | phospholipase inhibitor activity(GO:0004859) phospholipase A2 inhibitor activity(GO:0019834) lipase inhibitor activity(GO:0055102) |
| 0.8 | 2.5 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.8 | 15.8 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.8 | 0.8 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 0.8 | 13.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.8 | 17.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.8 | 2.4 | GO:0019120 | hydrolase activity, acting on acid halide bonds(GO:0016824) hydrolase activity, acting on acid halide bonds, in C-halide compounds(GO:0019120) alkylhalidase activity(GO:0047651) |
| 0.8 | 10.5 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
| 0.8 | 3.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.8 | 17.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.8 | 8.0 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.8 | 2.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.8 | 5.6 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.8 | 3.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.8 | 3.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.8 | 10.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.8 | 3.9 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.8 | 9.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.8 | 3.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.8 | 17.0 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.8 | 3.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.8 | 0.8 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.8 | 2.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.8 | 1.5 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.8 | 9.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.8 | 3.1 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.8 | 19.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.8 | 2.3 | GO:0004454 | ketohexokinase activity(GO:0004454) |
| 0.8 | 29.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.8 | 14.4 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.8 | 6.1 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.8 | 2.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 0.8 | 2.3 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.8 | 3.8 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.7 | 3.7 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
| 0.7 | 11.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.7 | 8.2 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
| 0.7 | 4.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.7 | 1.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.7 | 2.2 | GO:0004686 | elongation factor-2 kinase activity(GO:0004686) |
| 0.7 | 2.2 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.7 | 18.4 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.7 | 2.9 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.7 | 3.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.7 | 2.9 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.7 | 16.0 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.7 | 4.3 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.7 | 2.9 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.7 | 2.8 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.7 | 2.8 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
| 0.7 | 2.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.7 | 2.8 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.7 | 12.0 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.7 | 17.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.7 | 2.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.7 | 2.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.7 | 5.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.7 | 9.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.7 | 2.7 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.7 | 2.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.7 | 2.0 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
| 0.7 | 9.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.7 | 4.7 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.7 | 2.0 | GO:0030249 | cyclase regulator activity(GO:0010851) guanylate cyclase regulator activity(GO:0030249) |
| 0.7 | 2.0 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.7 | 5.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.7 | 3.3 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.7 | 9.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.7 | 5.2 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
| 0.7 | 2.0 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
| 0.7 | 2.6 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.7 | 15.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.6 | 4.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.6 | 3.9 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.6 | 6.5 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.6 | 0.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.6 | 1.3 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 0.6 | 1.3 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.6 | 13.3 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
| 0.6 | 3.1 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
| 0.6 | 4.4 | GO:0015288 | porin activity(GO:0015288) |
| 0.6 | 3.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) G-protein coupled neurotransmitter receptor activity(GO:0099528) |
| 0.6 | 9.3 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.6 | 1.9 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.6 | 4.3 | GO:0000182 | rDNA binding(GO:0000182) |
| 0.6 | 3.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.6 | 5.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 0.6 | 1.8 | GO:0001016 | RNA polymerase III regulatory region DNA binding(GO:0001016) peroxynitrite reductase activity(GO:0072541) |
| 0.6 | 3.6 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.6 | 4.8 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.6 | 5.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 0.6 | 2.4 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
| 0.6 | 4.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.6 | 13.5 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
| 0.6 | 46.8 | GO:0005178 | integrin binding(GO:0005178) |
| 0.6 | 1.8 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.6 | 5.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.6 | 1.8 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
| 0.6 | 0.6 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.6 | 3.5 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
| 0.6 | 2.9 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
| 0.6 | 1.7 | GO:0031403 | lithium ion binding(GO:0031403) |
| 0.6 | 9.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.6 | 3.4 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.6 | 2.2 | GO:0042910 | xenobiotic transporter activity(GO:0042910) |
| 0.6 | 2.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.5 | 14.3 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.5 | 12.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.5 | 2.2 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
| 0.5 | 2.2 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.5 | 1.6 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 0.5 | 26.4 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.5 | 9.1 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.5 | 1.6 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.5 | 2.7 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.5 | 1.6 | GO:0001888 | glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0001888) glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
| 0.5 | 40.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.5 | 2.6 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.5 | 5.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
| 0.5 | 1.0 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.5 | 8.4 | GO:0008373 | sialyltransferase activity(GO:0008373) |
| 0.5 | 4.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
| 0.5 | 5.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.5 | 5.6 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
| 0.5 | 2.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.5 | 5.6 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
| 0.5 | 2.5 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
| 0.5 | 1.0 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.5 | 1.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.5 | 2.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 0.5 | 1.0 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
| 0.5 | 3.5 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.5 | 2.0 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.5 | 32.4 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.5 | 1.0 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
| 0.5 | 1.5 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
| 0.5 | 2.4 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
| 0.5 | 2.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.5 | 9.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.5 | 2.4 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.5 | 1.9 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.5 | 1.4 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.5 | 16.0 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.5 | 2.3 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.5 | 3.3 | GO:0015925 | galactosidase activity(GO:0015925) |
| 0.5 | 1.4 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.5 | 1.8 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.5 | 28.5 | GO:0008201 | heparin binding(GO:0008201) |
| 0.5 | 5.5 | GO:0015298 | solute:cation antiporter activity(GO:0015298) |
| 0.5 | 1.8 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.5 | 4.1 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.5 | 1.4 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.5 | 1.8 | GO:0030955 | potassium ion binding(GO:0030955) |
| 0.4 | 1.8 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.4 | 7.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
| 0.4 | 1.3 | GO:0017084 | glutamate 5-kinase activity(GO:0004349) glutamate-5-semialdehyde dehydrogenase activity(GO:0004350) delta1-pyrroline-5-carboxylate synthetase activity(GO:0017084) amino acid kinase activity(GO:0019202) |
| 0.4 | 11.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.4 | 0.4 | GO:0048256 | flap endonuclease activity(GO:0048256) |
| 0.4 | 1.3 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.4 | 2.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
| 0.4 | 3.5 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.4 | 1.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
| 0.4 | 3.5 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.4 | 2.6 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.4 | 1.3 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
| 0.4 | 2.5 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.4 | 2.1 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.4 | 1.7 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.4 | 0.8 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
| 0.4 | 1.7 | GO:0033883 | pyridoxal phosphatase activity(GO:0033883) |
| 0.4 | 3.7 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.4 | 2.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.4 | 1.6 | GO:0004441 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) |
| 0.4 | 9.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.4 | 4.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.4 | 1.6 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 0.4 | 0.8 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
| 0.4 | 5.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
| 0.4 | 11.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.4 | 13.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.4 | 3.6 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
| 0.4 | 1.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.4 | 1.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.4 | 3.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.4 | 10.2 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.4 | 1.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
| 0.4 | 2.0 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.4 | 0.8 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
| 0.4 | 6.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.4 | 1.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.4 | 3.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.4 | 0.8 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.4 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.4 | 1.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.4 | 1.2 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
| 0.4 | 4.6 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 0.4 | 0.8 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
| 0.4 | 0.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.4 | 1.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.4 | 1.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.4 | 0.4 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
| 0.4 | 0.4 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.4 | 1.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.4 | 1.1 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.4 | 2.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.4 | 0.7 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.4 | 5.1 | GO:0048038 | quinone binding(GO:0048038) |
| 0.4 | 0.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.4 | 1.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.4 | 1.4 | GO:2001069 | glycogen binding(GO:2001069) |
| 0.4 | 1.1 | GO:0008176 | tRNA (guanine-N7-)-methyltransferase activity(GO:0008176) |
| 0.4 | 7.2 | GO:0005521 | lamin binding(GO:0005521) |
| 0.4 | 1.8 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.4 | 1.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.4 | 0.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.4 | 1.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.3 | 0.7 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
| 0.3 | 2.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.3 | 1.4 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.3 | 5.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.3 | 25.1 | GO:0005125 | cytokine activity(GO:0005125) |
| 0.3 | 1.4 | GO:1901612 | phosphatidylglycerol binding(GO:1901611) cardiolipin binding(GO:1901612) |
| 0.3 | 2.0 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.3 | 1.0 | GO:0004980 | melanocortin receptor activity(GO:0004977) melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.3 | 3.0 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
| 0.3 | 0.3 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.3 | 1.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.3 | 1.3 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.3 | 2.3 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.3 | 3.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.3 | 1.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.3 | 7.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.3 | 2.9 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.3 | 3.8 | GO:0005537 | mannose binding(GO:0005537) |
| 0.3 | 4.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.3 | 13.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.3 | 2.9 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.3 | 5.7 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.3 | 0.6 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.3 | 10.7 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.3 | 0.9 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.3 | 1.5 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.3 | 10.1 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.3 | 3.9 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.3 | 0.9 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.3 | 1.2 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.3 | 1.5 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.3 | 14.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.3 | 2.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
| 0.3 | 0.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 0.3 | 0.6 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.3 | 17.3 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.3 | 0.6 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.3 | 9.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.3 | 7.8 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
| 0.3 | 0.8 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.3 | 0.6 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.3 | 6.6 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.3 | 0.8 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.3 | 44.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.3 | 0.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.3 | 1.6 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
| 0.3 | 2.2 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.3 | 1.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.3 | 1.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.3 | 0.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.3 | 0.8 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
| 0.3 | 2.4 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
| 0.3 | 2.1 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
| 0.3 | 0.5 | GO:0015929 | hexosaminidase activity(GO:0015929) |
| 0.3 | 1.0 | GO:0035514 | DNA demethylase activity(GO:0035514) |
| 0.3 | 16.7 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.3 | 0.8 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.3 | 4.6 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.3 | 0.8 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
| 0.3 | 1.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.3 | 1.0 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.2 | 1.2 | GO:1990188 | euchromatin binding(GO:1990188) |
| 0.2 | 1.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.2 | 2.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.2 | 1.7 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
| 0.2 | 0.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.2 | 63.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.2 | 20.0 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.2 | 1.4 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
| 0.2 | 0.7 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.2 | 0.5 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.2 | 0.5 | GO:0022839 | ion gated channel activity(GO:0022839) |
| 0.2 | 1.4 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.2 | 0.5 | GO:0004103 | choline kinase activity(GO:0004103) |
| 0.2 | 3.2 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.2 | 1.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.2 | 1.8 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.2 | 0.2 | GO:0035877 | death effector domain binding(GO:0035877) |
| 0.2 | 14.5 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.2 | 1.4 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.2 | 1.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
| 0.2 | 0.9 | GO:1990715 | mRNA CDS binding(GO:1990715) |
| 0.2 | 1.1 | GO:0001849 | opsonin binding(GO:0001846) complement component C1q binding(GO:0001849) |
| 0.2 | 1.8 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.2 | 0.7 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.2 | 2.0 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.2 | 2.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 0.2 | 6.6 | GO:0042562 | hormone binding(GO:0042562) |
| 0.2 | 0.7 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.2 | 1.3 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.2 | 1.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.2 | 0.4 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.2 | 1.1 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 0.2 | 1.1 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
| 0.2 | 7.4 | GO:0019239 | deaminase activity(GO:0019239) |
| 0.2 | 8.1 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.2 | 2.3 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.2 | 1.3 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 0.2 | 1.0 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.2 | 3.1 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.2 | 0.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.2 | 1.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.2 | 2.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.2 | 1.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.2 | 4.3 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.2 | 1.6 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
| 0.2 | 0.8 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.2 | 4.6 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.2 | 2.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.2 | 2.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.2 | 4.5 | GO:0072509 | divalent inorganic cation transmembrane transporter activity(GO:0072509) |
| 0.2 | 1.1 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.2 | 0.6 | GO:0098809 | nitrite reductase activity(GO:0098809) |
| 0.2 | 0.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.2 | 0.2 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.2 | 0.2 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.2 | 4.5 | GO:0001223 | transcription coactivator binding(GO:0001223) |
| 0.2 | 2.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.2 | 1.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.2 | 0.9 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.2 | 2.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.2 | 0.5 | GO:0071253 | connexin binding(GO:0071253) |
| 0.2 | 10.8 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.2 | 2.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.2 | 0.7 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.2 | 0.5 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.2 | 0.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.2 | 0.5 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.2 | 0.6 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
| 0.2 | 5.4 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.2 | 0.5 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.2 | 0.8 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.2 | 1.7 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.2 | 1.1 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.2 | 3.3 | GO:0042277 | peptide binding(GO:0042277) |
| 0.2 | 4.7 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.2 | 1.1 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
| 0.1 | 0.3 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
| 0.1 | 0.3 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) |
| 0.1 | 2.3 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.1 | 0.4 | GO:0019779 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
| 0.1 | 0.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.1 | 6.9 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.1 | 0.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
| 0.1 | 1.3 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.1 | 0.3 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
| 0.1 | 0.7 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) |
| 0.1 | 0.7 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.1 | 0.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.1 | 0.1 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 0.1 | 0.4 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
| 0.1 | 1.0 | GO:0010181 | FMN binding(GO:0010181) |
| 0.1 | 0.6 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.1 | 0.9 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.1 | 5.1 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.1 | 4.0 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
| 0.1 | 5.2 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.1 | 1.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 0.1 | 1.1 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.1 | 0.5 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.1 | 1.8 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
| 0.1 | 0.4 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.1 | 0.5 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.1 | 0.1 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
| 0.1 | 0.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.1 | 0.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.1 | 3.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
| 0.1 | 0.7 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.1 | 0.2 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
| 0.1 | 0.2 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.1 | 0.5 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.1 | 0.6 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.1 | 0.4 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 0.3 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
| 0.1 | 0.2 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 0.1 | 0.2 | GO:0051378 | serotonin binding(GO:0051378) |
| 0.1 | 0.9 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 0.1 | 2.6 | GO:0015297 | antiporter activity(GO:0015297) |
| 0.1 | 0.5 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 0.4 | GO:0031685 | adenosine receptor binding(GO:0031685) |
| 0.1 | 0.3 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
| 0.1 | 0.3 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.1 | 1.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
| 0.1 | 1.8 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.1 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
| 0.1 | 0.3 | GO:0089720 | caspase binding(GO:0089720) |
| 0.1 | 0.2 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
| 0.1 | 0.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.1 | 0.5 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.1 | 0.4 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
| 0.1 | 0.8 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.1 | 1.3 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.1 | 0.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.1 | 1.5 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.1 | 0.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.1 | 0.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
| 0.1 | 0.6 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.1 | 0.6 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.1 | 1.4 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.1 | 0.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.1 | 0.5 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.1 | 0.3 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 0.1 | 0.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.1 | 0.5 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.1 | 2.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.1 | 0.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.1 | 0.6 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.1 | 0.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.1 | 0.2 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
| 0.1 | 0.9 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
| 0.1 | 5.3 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
| 0.1 | 0.4 | GO:0030275 | LRR domain binding(GO:0030275) |
| 0.1 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 0.0 | 0.1 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
| 0.0 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
| 0.0 | 0.9 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
| 0.0 | 0.5 | GO:0005522 | profilin binding(GO:0005522) |
| 0.0 | 0.3 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.0 | 0.4 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.0 | 0.3 | GO:0015266 | protein channel activity(GO:0015266) |
| 0.0 | 0.6 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.0 | 0.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.0 | 0.2 | GO:0001653 | peptide receptor activity(GO:0001653) G-protein coupled peptide receptor activity(GO:0008528) |
| 0.0 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.0 | 0.4 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.0 | 0.0 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.0 | 0.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.0 | 0.1 | GO:0001847 | opsonin receptor activity(GO:0001847) |
| 0.0 | 0.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.0 | 0.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.0 | 0.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.0 | 0.1 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.0 | 0.3 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.0 | 0.0 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.0 | 0.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.0 | 0.1 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.6 | 2.6 | PID_IFNG_PATHWAY | IFN-gamma pathway |
| 2.5 | 17.4 | ST_PAC1_RECEPTOR_PATHWAY | PAC1 Receptor Pathway |
| 2.0 | 33.4 | PID_LPA4_PATHWAY | LPA4-mediated signaling events |
| 1.8 | 5.3 | PID_S1P_S1P1_PATHWAY | S1P1 pathway |
| 1.7 | 1.7 | ST_IL_13_PATHWAY | Interleukin 13 (IL-13) Pathway |
| 1.5 | 20.9 | ST_JAK_STAT_PATHWAY | Jak-STAT Pathway |
| 1.5 | 46.0 | PID_IL12_STAT4_PATHWAY | IL12 signaling mediated by STAT4 |
| 1.3 | 1.3 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
| 1.3 | 8.9 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 1.2 | 20.0 | PID_S1P_S1P4_PATHWAY | S1P4 pathway |
| 1.2 | 14.6 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
| 1.2 | 38.9 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
| 1.2 | 26.7 | ST_GA12_PATHWAY | G alpha 12 Pathway |
| 1.2 | 23.1 | PID_IL23_PATHWAY | IL23-mediated signaling events |
| 1.1 | 48.0 | PID_SHP2_PATHWAY | SHP2 signaling |
| 1.1 | 30.3 | ST_INTERLEUKIN_4_PATHWAY | Interleukin 4 (IL-4) Pathway |
| 1.0 | 14.5 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
| 1.0 | 4.0 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 1.0 | 3.9 | ST_TYPE_I_INTERFERON_PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.9 | 7.6 | PID_ALK2_PATHWAY | ALK2 signaling events |
| 0.9 | 32.4 | NABA_BASEMENT_MEMBRANES | Genes encoding structural components of basement membranes |
| 0.9 | 14.8 | ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY | PI3K Pathway |
| 0.9 | 30.4 | PID_RAS_PATHWAY | Regulation of Ras family activation |
| 0.9 | 16.9 | PID_P38_GAMMA_DELTA_PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.9 | 17.6 | PID_UPA_UPAR_PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.8 | 6.7 | PID_INTEGRIN_CS_PATHWAY | Integrin family cell surface interactions |
| 0.8 | 10.8 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.8 | 98.7 | NABA_ECM_GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.8 | 15.2 | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.8 | 20.0 | PID_A6B1_A6B4_INTEGRIN_PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.8 | 20.3 | PID_PI3K_PLC_TRK_PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.7 | 19.1 | PID_RXR_VDR_PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.7 | 16.4 | PID_ENDOTHELIN_PATHWAY | Endothelins |
| 0.7 | 2.7 | PID_IL8_CXCR1_PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.7 | 2.0 | PID_SYNDECAN_1_PATHWAY | Syndecan-1-mediated signaling events |
| 0.7 | 12.7 | PID_CIRCADIAN_PATHWAY | Circadian rhythm pathway |
| 0.6 | 1.3 | PID_LYMPH_ANGIOGENESIS_PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.6 | 19.8 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.6 | 5.9 | PID_CD8_TCR_DOWNSTREAM_PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.6 | 6.9 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
| 0.6 | 9.7 | PID_IL2_STAT5_PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.6 | 4.5 | PID_ANGIOPOIETIN_RECEPTOR_PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.6 | 8.3 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.5 | 12.2 | PID_TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.5 | 6.8 | PID_HIV_NEF_PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.5 | 11.9 | PID_TNF_PATHWAY | TNF receptor signaling pathway |
| 0.5 | 14.9 | ST_TUMOR_NECROSIS_FACTOR_PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.5 | 3.4 | PID_ANTHRAX_PATHWAY | Cellular roles of Anthrax toxin |
| 0.5 | 20.0 | PID_INSULIN_PATHWAY | Insulin Pathway |
| 0.5 | 10.2 | PID_IL12_2PATHWAY | IL12-mediated signaling events |
| 0.5 | 4.3 | PID_CD8_TCR_PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.5 | 3.8 | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.5 | 6.6 | PID_EPO_PATHWAY | EPO signaling pathway |
| 0.5 | 3.3 | PID_FAS_PATHWAY | FAS (CD95) signaling pathway |
| 0.5 | 11.9 | PID_REELIN_PATHWAY | Reelin signaling pathway |
| 0.5 | 5.5 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
| 0.4 | 1.3 | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.4 | 5.8 | PID_INSULIN_GLUCOSE_PATHWAY | Insulin-mediated glucose transport |
| 0.4 | 3.5 | PID_GMCSF_PATHWAY | GMCSF-mediated signaling events |
| 0.4 | 11.2 | PID_MYC_PATHWAY | C-MYC pathway |
| 0.4 | 6.0 | PID_LYSOPHOSPHOLIPID_PATHWAY | LPA receptor mediated events |
| 0.4 | 6.4 | PID_SYNDECAN_3_PATHWAY | Syndecan-3-mediated signaling events |
| 0.4 | 6.5 | PID_NECTIN_PATHWAY | Nectin adhesion pathway |
| 0.4 | 7.6 | PID_EPHRINB_REV_PATHWAY | Ephrin B reverse signaling |
| 0.4 | 9.6 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.4 | 51.0 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.4 | 7.0 | PID_BCR_5PATHWAY | BCR signaling pathway |
| 0.4 | 23.5 | PID_ERBB1_DOWNSTREAM_PATHWAY | ErbB1 downstream signaling |
| 0.4 | 6.7 | PID_TRAIL_PATHWAY | TRAIL signaling pathway |
| 0.4 | 11.8 | PID_AR_TF_PATHWAY | Regulation of Androgen receptor activity |
| 0.3 | 2.4 | NABA_CORE_MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
| 0.3 | 5.4 | PID_LIS1_PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.3 | 4.3 | PID_IL1_PATHWAY | IL1-mediated signaling events |
| 0.3 | 2.6 | PID_ERBB2_ERBB3_PATHWAY | ErbB2/ErbB3 signaling events |
| 0.3 | 1.6 | PID_S1P_META_PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
| 0.3 | 8.7 | PID_ARF_3PATHWAY | Arf1 pathway |
| 0.3 | 52.7 | NABA_SECRETED_FACTORS | Genes encoding secreted soluble factors |
| 0.3 | 2.4 | ST_MYOCYTE_AD_PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.3 | 2.7 | PID_FCER1_PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.3 | 16.2 | PID_LKB1_PATHWAY | LKB1 signaling events |
| 0.3 | 15.2 | PID_MYC_REPRESS_PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.3 | 8.3 | PID_BMP_PATHWAY | BMP receptor signaling |
| 0.3 | 11.7 | PID_AP1_PATHWAY | AP-1 transcription factor network |
| 0.3 | 1.1 | SIG_BCR_SIGNALING_PATHWAY | Members of the BCR signaling pathway |
| 0.3 | 6.6 | PID_DNA_PK_PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.3 | 2.0 | PID_RHODOPSIN_PATHWAY | Visual signal transduction: Rods |
| 0.2 | 2.9 | PID_ALPHA_SYNUCLEIN_PATHWAY | Alpha-synuclein signaling |
| 0.2 | 10.9 | PID_RHOA_REG_PATHWAY | Regulation of RhoA activity |
| 0.2 | 4.0 | PID_EPHB_FWD_PATHWAY | EPHB forward signaling |
| 0.2 | 2.7 | PID_PI3KCI_PATHWAY | Class I PI3K signaling events |
| 0.2 | 7.3 | PID_HNF3A_PATHWAY | FOXA1 transcription factor network |
| 0.2 | 0.2 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.2 | 6.7 | PID_RAC1_REG_PATHWAY | Regulation of RAC1 activity |
| 0.2 | 2.2 | PID_IL2_1PATHWAY | IL2-mediated signaling events |
| 0.2 | 1.9 | PID_ERBB1_INTERNALIZATION_PATHWAY | Internalization of ErbB1 |
| 0.2 | 1.9 | PID_TCR_PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.2 | 10.1 | PID_P53_REGULATION_PATHWAY | p53 pathway |
| 0.2 | 0.3 | PID_AR_NONGENOMIC_PATHWAY | Nongenotropic Androgen signaling |
| 0.2 | 0.6 | PID_ARF6_DOWNSTREAM_PATHWAY | Arf6 downstream pathway |
| 0.1 | 0.9 | ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.1 | 1.2 | PID_KIT_PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 4.1 | PID_REG_GR_PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 1.4 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 3.3 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 1.9 | PID_ARF6_TRAFFICKING_PATHWAY | Arf6 trafficking events |
| 0.1 | 1.7 | PID_P75_NTR_PATHWAY | p75(NTR)-mediated signaling |
| 0.1 | 1.5 | PID_NCADHERIN_PATHWAY | N-cadherin signaling events |
| 0.1 | 2.2 | PID_MET_PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.1 | 1.2 | PID_CDC42_REG_PATHWAY | Regulation of CDC42 activity |
| 0.1 | 0.2 | PID_VEGFR1_PATHWAY | VEGFR1 specific signals |
| 0.1 | 2.3 | PID_MTOR_4PATHWAY | mTOR signaling pathway |
| 0.1 | 0.7 | PID_EPHA_FWDPATHWAY | EPHA forward signaling |
| 0.1 | 1.1 | PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.1 | 0.3 | SA_PTEN_PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.1 | 0.8 | PID_PDGFRB_PATHWAY | PDGFR-beta signaling pathway |
| 0.1 | 0.7 | PID_HDAC_CLASSIII_PATHWAY | Signaling events mediated by HDAC Class III |
| 0.0 | 1.7 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.0 | 0.3 | PID_P38_MKK3_6PATHWAY | p38 MAPK signaling pathway |
| 0.0 | 0.4 | PID_TRKR_PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.0 | 0.5 | PID_RB_1PATHWAY | Regulation of retinoblastoma protein |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.6 | 14.4 | REACTOME_GLYCOPROTEIN_HORMONES | Genes involved in Glycoprotein hormones |
| 2.5 | 17.6 | REACTOME_ENDOGENOUS_STEROLS | Genes involved in Endogenous sterols |
| 2.4 | 7.3 | REACTOME_SEROTONIN_RECEPTORS | Genes involved in Serotonin receptors |
| 2.3 | 2.3 | REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 2.1 | 31.7 | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | Genes involved in Degradation of the extracellular matrix |
| 1.9 | 1.9 | REACTOME_PRE_NOTCH_TRANSCRIPTION_AND_TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 1.8 | 1.8 | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 1.8 | 35.6 | REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 1.7 | 17.1 | REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 1.7 | 1.7 | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | Genes involved in Post NMDA receptor activation events |
| 1.6 | 20.3 | REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 1.5 | 10.8 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 1.5 | 5.9 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PS | Genes involved in Acyl chain remodelling of PS |
| 1.5 | 20.5 | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 1.4 | 16.9 | REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY | Genes involved in Adenylate cyclase activating pathway |
| 1.4 | 11.0 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PI | Genes involved in Acyl chain remodelling of PI |
| 1.3 | 7.9 | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 1.3 | 15.6 | REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 1.3 | 40.7 | REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 1.3 | 3.8 | REACTOME_RORA_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in RORA Activates Circadian Expression |
| 1.3 | 16.5 | REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 1.3 | 3.8 | REACTOME_IL_6_SIGNALING | Genes involved in Interleukin-6 signaling |
| 1.2 | 14.4 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 1.2 | 10.7 | REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN1_SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
| 1.2 | 9.3 | REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 1.1 | 5.7 | REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 1.1 | 13.5 | REACTOME_IL_7_SIGNALING | Genes involved in Interleukin-7 signaling |
| 1.1 | 9.9 | REACTOME_PHOSPHORYLATION_OF_CD3_AND_TCR_ZETA_CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
| 1.1 | 2.2 | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | Genes involved in Cell surface interactions at the vascular wall |
| 1.1 | 14.1 | REACTOME_HDL_MEDIATED_LIPID_TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 1.0 | 3.1 | REACTOME_ADP_SIGNALLING_THROUGH_P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
| 1.0 | 31.2 | REACTOME_BASIGIN_INTERACTIONS | Genes involved in Basigin interactions |
| 1.0 | 24.0 | REACTOME_SYNTHESIS_OF_PC | Genes involved in Synthesis of PC |
| 1.0 | 1.0 | REACTOME_ARMS_MEDIATED_ACTIVATION | Genes involved in ARMS-mediated activation |
| 1.0 | 5.8 | REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 1.0 | 9.6 | REACTOME_PROTEOLYTIC_CLEAVAGE_OF_SNARE_COMPLEX_PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
| 1.0 | 18.1 | REACTOME_ABCA_TRANSPORTERS_IN_LIPID_HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.9 | 9.4 | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.9 | 8.4 | REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.9 | 16.6 | REACTOME_ACTIVATION_OF_THE_AP1_FAMILY_OF_TRANSCRIPTION_FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.9 | 0.9 | REACTOME_PI3K_CASCADE | Genes involved in PI3K Cascade |
| 0.9 | 11.0 | REACTOME_REGULATION_OF_IFNA_SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.8 | 20.4 | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.8 | 18.0 | REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.8 | 2.4 | REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.8 | 15.3 | REACTOME_ERK_MAPK_TARGETS | Genes involved in ERK/MAPK targets |
| 0.8 | 1.6 | REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.8 | 0.8 | REACTOME_PD1_SIGNALING | Genes involved in PD-1 signaling |
| 0.8 | 19.6 | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
| 0.8 | 10.1 | REACTOME_PLATELET_SENSITIZATION_BY_LDL | Genes involved in Platelet sensitization by LDL |
| 0.8 | 3.8 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
| 0.8 | 3.8 | REACTOME_BILE_SALT_AND_ORGANIC_ANION_SLC_TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.8 | 4.5 | REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.7 | 7.4 | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.7 | 6.6 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.7 | 10.2 | REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.7 | 68.1 | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.7 | 15.6 | REACTOME_INSULIN_RECEPTOR_RECYCLING | Genes involved in Insulin receptor recycling |
| 0.7 | 0.7 | REACTOME_IL_3_5_AND_GM_CSF_SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
| 0.7 | 9.6 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.7 | 8.9 | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.7 | 23.1 | REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.7 | 6.1 | REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER | Genes involved in Formation of incision complex in GG-NER |
| 0.7 | 17.1 | REACTOME_RAP1_SIGNALLING | Genes involved in Rap1 signalling |
| 0.7 | 44.3 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.6 | 7.0 | REACTOME_ROLE_OF_DCC_IN_REGULATING_APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.6 | 6.4 | REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.6 | 16.7 | REACTOME_INTERFERON_ALPHA_BETA_SIGNALING | Genes involved in Interferon alpha/beta signaling |
| 0.6 | 2.4 | REACTOME_CS_DS_DEGRADATION | Genes involved in CS/DS degradation |
| 0.6 | 13.1 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.6 | 4.7 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_GLUCAGON_LIKE_PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.6 | 4.7 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.6 | 0.6 | REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 0.6 | 8.8 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.6 | 2.3 | REACTOME_INHIBITION_OF_INSULIN_SECRETION_BY_ADRENALINE_NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.6 | 11.0 | REACTOME_CRMPS_IN_SEMA3A_SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.6 | 12.0 | REACTOME_RNA_POL_III_CHAIN_ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.6 | 23.8 | REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.6 | 19.7 | REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.6 | 5.0 | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.6 | 2.2 | REACTOME_DSCAM_INTERACTIONS | Genes involved in DSCAM interactions |
| 0.5 | 1.1 | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.5 | 6.5 | REACTOME_GLYCOLYSIS | Genes involved in Glycolysis |
| 0.5 | 15.5 | REACTOME_SYNTHESIS_OF_PA | Genes involved in Synthesis of PA |
| 0.5 | 2.1 | REACTOME_ANDROGEN_BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.5 | 6.9 | REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.5 | 0.5 | REACTOME_SIGNALING_BY_CONSTITUTIVELY_ACTIVE_EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.5 | 8.3 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.5 | 30.1 | REACTOME_COLLAGEN_FORMATION | Genes involved in Collagen formation |
| 0.5 | 5.9 | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.5 | 11.1 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.5 | 7.7 | REACTOME_MTORC1_MEDIATED_SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.5 | 6.2 | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.5 | 12.4 | REACTOME_METAL_ION_SLC_TRANSPORTERS | Genes involved in Metal ion SLC transporters |
| 0.5 | 4.8 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.5 | 13.3 | REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
| 0.5 | 18.1 | REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
| 0.5 | 8.8 | REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.5 | 7.4 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.5 | 2.3 | REACTOME_ACTIVATION_OF_RAC | Genes involved in Activation of Rac |
| 0.5 | 9.9 | REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.5 | 2.3 | REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.4 | 5.8 | REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.4 | 3.1 | REACTOME_THE_NLRP3_INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
| 0.4 | 6.2 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.4 | 8.4 | REACTOME_ALPHA_LINOLENIC_ACID_ALA_METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.4 | 3.1 | REACTOME_GAP_JUNCTION_DEGRADATION | Genes involved in Gap junction degradation |
| 0.4 | 8.0 | REACTOME_ACTIVATION_OF_GENES_BY_ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.4 | 3.7 | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.4 | 0.8 | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.4 | 1.6 | REACTOME_COMMON_PATHWAY | Genes involved in Common Pathway |
| 0.4 | 17.1 | REACTOME_NETRIN1_SIGNALING | Genes involved in Netrin-1 signaling |
| 0.4 | 8.9 | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.4 | 8.3 | REACTOME_GLUTATHIONE_CONJUGATION | Genes involved in Glutathione conjugation |
| 0.4 | 3.2 | REACTOME_GLUCOSE_TRANSPORT | Genes involved in Glucose transport |
| 0.4 | 3.6 | REACTOME_EXTRINSIC_PATHWAY_FOR_APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.4 | 23.3 | REACTOME_CELL_JUNCTION_ORGANIZATION | Genes involved in Cell junction organization |
| 0.4 | 11.0 | REACTOME_RAS_ACTIVATION_UOPN_CA2_INFUX_THROUGH_NMDA_RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.4 | 8.0 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
| 0.4 | 5.8 | REACTOME_UNWINDING_OF_DNA | Genes involved in Unwinding of DNA |
| 0.4 | 1.8 | REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.4 | 11.3 | REACTOME_GLYCOSPHINGOLIPID_METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.4 | 11.9 | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.3 | 1.0 | REACTOME_ACTIVATION_OF_CHAPERONES_BY_ATF6_ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
| 0.3 | 1.0 | REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.3 | 3.4 | REACTOME_TAK1_ACTIVATES_NFKB_BY_PHOSPHORYLATION_AND_ACTIVATION_OF_IKKS_COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| 0.3 | 17.9 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.3 | 3.1 | REACTOME_FRS2_MEDIATED_CASCADE | Genes involved in FRS2-mediated cascade |
| 0.3 | 1.7 | REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
| 0.3 | 7.3 | REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.3 | 13.2 | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | Genes involved in NCAM signaling for neurite out-growth |
| 0.3 | 2.2 | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.3 | 3.1 | REACTOME_REMOVAL_OF_THE_FLAP_INTERMEDIATE_FROM_THE_C_STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.3 | 4.9 | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.3 | 5.1 | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.3 | 3.3 | REACTOME_G_ALPHA1213_SIGNALLING_EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.3 | 5.3 | REACTOME_SULFUR_AMINO_ACID_METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.3 | 4.6 | REACTOME_IL1_SIGNALING | Genes involved in Interleukin-1 signaling |
| 0.3 | 4.9 | REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.3 | 9.5 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.3 | 0.6 | REACTOME_SIGNALING_BY_NOTCH | Genes involved in Signaling by NOTCH |
| 0.3 | 1.1 | REACTOME_NEGATIVE_REGULATION_OF_FGFR_SIGNALING | Genes involved in Negative regulation of FGFR signaling |
| 0.3 | 1.1 | REACTOME_REGULATION_OF_COMPLEMENT_CASCADE | Genes involved in Regulation of Complement cascade |
| 0.3 | 0.8 | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR | Genes involved in Downstream signaling of activated FGFR |
| 0.3 | 5.5 | REACTOME_PEROXISOMAL_LIPID_METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.3 | 43.4 | REACTOME_SIGNALING_BY_RHO_GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.3 | 2.5 | REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.3 | 34.6 | REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.3 | 3.8 | REACTOME_GABA_A_RECEPTOR_ACTIVATION | Genes involved in GABA A receptor activation |
| 0.3 | 4.2 | REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.3 | 13.2 | REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2_ | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 0.3 | 2.0 | REACTOME_MEMBRANE_BINDING_AND_TARGETTING_OF_GAG_PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 0.3 | 2.8 | REACTOME_REGULATION_OF_RHEB_GTPASE_ACTIVITY_BY_AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.2 | 5.4 | REACTOME_RNA_POL_I_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.2 | 1.2 | REACTOME_ER_PHAGOSOME_PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.2 | 2.6 | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.2 | 12.6 | REACTOME_AMYLOIDS | Genes involved in Amyloids |
| 0.2 | 7.3 | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.2 | 1.1 | REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.2 | 0.2 | REACTOME_IRON_UPTAKE_AND_TRANSPORT | Genes involved in Iron uptake and transport |
| 0.2 | 10.0 | REACTOME_UNFOLDED_PROTEIN_RESPONSE | Genes involved in Unfolded Protein Response |
| 0.2 | 0.4 | REACTOME_SHC_RELATED_EVENTS | Genes involved in SHC-related events |
| 0.2 | 0.2 | REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.2 | 1.3 | REACTOME_NOD1_2_SIGNALING_PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.2 | 1.5 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 5.2 | REACTOME_NUCLEAR_SIGNALING_BY_ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.2 | 1.4 | REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.2 | 0.6 | REACTOME_SYNTHESIS_OF_PE | Genes involved in Synthesis of PE |
| 0.2 | 1.5 | REACTOME_CTNNB1_PHOSPHORYLATION_CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.2 | 2.0 | REACTOME_FACILITATIVE_NA_INDEPENDENT_GLUCOSE_TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.2 | 3.1 | REACTOME_PURINE_SALVAGE | Genes involved in Purine salvage |
| 0.2 | 7.0 | REACTOME_INWARDLY_RECTIFYING_K_CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.2 | 0.2 | REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.2 | 1.0 | REACTOME_NEPHRIN_INTERACTIONS | Genes involved in Nephrin interactions |
| 0.2 | 4.1 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.2 | 1.0 | REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.2 | 21.2 | REACTOME_FATTY_ACID_TRIACYLGLYCEROL_AND_KETONE_BODY_METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
| 0.2 | 11.6 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT | Genes involved in Respiratory electron transport |
| 0.2 | 12.5 | REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.2 | 0.7 | REACTOME_FORMATION_OF_TRANSCRIPTION_COUPLED_NER_TC_NER_REPAIR_COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.2 | 4.2 | REACTOME_NONSENSE_MEDIATED_DECAY_ENHANCED_BY_THE_EXON_JUNCTION_COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
| 0.2 | 2.1 | REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.2 | 0.2 | REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.2 | 2.2 | REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.1 | 2.9 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.1 | 3.3 | REACTOME_DOUBLE_STRAND_BREAK_REPAIR | Genes involved in Double-Strand Break Repair |
| 0.1 | 3.3 | REACTOME_SIGNALING_BY_BMP | Genes involved in Signaling by BMP |
| 0.1 | 3.4 | REACTOME_SMOOTH_MUSCLE_CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.1 | 0.2 | REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
| 0.1 | 0.1 | REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.1 | 2.3 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 1.5 | REACTOME_PYRUVATE_METABOLISM | Genes involved in Pyruvate metabolism |
| 0.1 | 0.7 | REACTOME_RNA_POL_III_TRANSCRIPTION_INITIATION_FROM_TYPE_2_PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.1 | 5.1 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 0.5 | REACTOME_DESTABILIZATION_OF_MRNA_BY_TRISTETRAPROLIN_TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 0.4 | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.1 | 0.9 | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.1 | 0.2 | REACTOME_PEPTIDE_CHAIN_ELONGATION | Genes involved in Peptide chain elongation |
| 0.1 | 0.3 | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.0 | 6.1 | REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.0 | 1.7 | REACTOME_MEIOTIC_SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.0 | 1.5 | REACTOME_POTASSIUM_CHANNELS | Genes involved in Potassium Channels |
| 0.0 | 0.0 | REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.0 | 0.3 | REACTOME_INTERFERON_GAMMA_SIGNALING | Genes involved in Interferon gamma signaling |
| 0.0 | 0.3 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.0 | 0.1 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
